Dark | Light
# ![@Michigan_Value Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1799243134838165504.png) @Michigan_Value Michigan Value Investor

Michigan Value Investor posts on X about $hrow, $ionq, bloomberg, $rgti the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1799243134838165504/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:interactions.svg)


### Mentions: [--] [#](/creator/twitter::1799243134838165504/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:posts_active.svg)


### Followers: [-----] [#](/creator/twitter::1799243134838165504/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:followers.svg)


### CreatorRank: [-------] [#](/creator/twitter::1799243134838165504/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  [stocks](/list/stocks)  [technology brands](/list/technology-brands)  [cryptocurrencies](/list/cryptocurrencies)  [countries](/list/countries)  [social networks](/list/social-networks)  [exchanges](/list/exchanges)  [automotive brands](/list/automotive-brands) 

**Social topic influence**
[$hrow](/topic/$hrow) #2, [$ionq](/topic/$ionq), [bloomberg](/topic/bloomberg), [$rgti](/topic/$rgti), [money](/topic/money), [cvs](/topic/cvs) #205, [insurance](/topic/insurance), [$1b](/topic/$1b), [in the](/topic/in-the), [business](/topic/business)

**Top assets mentioned**
[IonQ, Inc. (IONQ)](/topic/$ionq) [Rigetti Computing, Inc. Common Stock (RGTI)](/topic/$rgti) [CVS Health Corp (CVS)](/topic/cvs) [D-Wave Quantum Inc. (QBTS)](/topic/$qbts) [Quantum Computing Inc. (QUBT)](/topic/$qubt) [GameStop, Corp. (GME)](/topic/$gme) [Bausch & Lomb Corp (BLCO)](/topic/$blco) [Nexstar Media Group, Inc. Class A Common Stock (NXST)](/topic/$nxst) [Atkore Inc. (ATKR)](/topic/$atkr) [Amazon.com, Inc. (AMZN)](/topic/$amzn) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Bitcoin (BTC)](/topic/bitcoin) [MemeCoin (MEME)](/topic/$meme) [SPDR S&P [---] ETF Trust (SPY)](/topic/$spy) [Joby Aviation, Inc. (JOBY)](/topic/$joby) [Berkshire Hathaway Inc Class B (BRK.B)](/topic/$brkb) [Alcon Inc. Ordinary Shares (ALC)](/topic/$alc)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Midwits think $ATKR doesn't have a moat bc it sells mostly commodity products. $COST sells mostly commodity products. Does $COST have a moat"  
[X Link](https://x.com/Michigan_Value/status/1809969861583356135)  2024-07-07T15:16Z [---] followers, [---] engagements


"@European_DGI Do you know what the buyback yield is after deducting share based comp"  
[X Link](https://x.com/Michigan_Value/status/1815028440094880064)  2024-07-21T14:17Z [---] followers, [---] engagements


"Something like 5% of political ad spending winds up as pre-tax FCF at $NXST. Who thinks political ad spending will do well this year And who thinks political ad spending is going to grow - every other year ofc - from here"  
[X Link](https://x.com/Michigan_Value/status/1815476117584654543)  2024-07-22T19:56Z [---] followers, [---] engagements


"Does anyone know how far along $CRWD is in their plan to change their ticker symbol to $OOPS"  
[X Link](https://x.com/Michigan_Value/status/1815785084361863364)  2024-07-23T16:24Z [---] followers, [---] engagements


"Is it obvious that $HROW would be cheap even if Vevye were their only product and they were losing money as they ramp it up That would be obvious right"  
[X Link](https://x.com/Michigan_Value/status/1818733982642557135)  2024-07-31T19:42Z [---] followers, [---] engagements


"@John_Hempton I mean yeah. I'm up 100% this year. I get why someone would pay me for investing advice. Why would anyone pay Cathy"  
[X Link](https://x.com/Michigan_Value/status/1821914394088861912)  2024-08-09T14:20Z [---] followers, [--] engagements


"This thread connects to $HROW eventually though it starts with $AMZN. People at funds who have done well are often unaware that they've been lucky and that can lead to mistakes. I'll give an example using myself"  
[X Link](https://x.com/Michigan_Value/status/1822650234347876829)  2024-08-11T15:04Z [---] followers, [---] engagements


"If I were your PM - and I've had that job - this is the conversation we would be having. Much like the conversation I had with myself about $AMZN. It made me a better investor to be so ruthless with myself btw. You're welcome"  
[X Link](https://x.com/Michigan_Value/status/1822650247010758784)  2024-08-11T15:04Z [---] followers, [---] engagements


"Just saw the most recent IQVIA data for $HROW's Vevye. Up and to the right is considered good right"  
[X Link](https://x.com/Michigan_Value/status/1823364907070288194)  2024-08-13T14:24Z [---] followers, [----] engagements


"OMG. I will get this right eventually. Vevye about to be fifth. Top [--] are restasis miebo generic cyclo and Xiidra"  
[X Link](https://x.com/Michigan_Value/status/1823479035416007093)  2024-08-13T21:57Z [---] followers, [---] engagements


"$HROW recent two week Vevye average is 3500/wk or about 15k/month. Pro-forma for $200 ASP fully insured they are running $3M/month right now. At this pace $75M Vevye in [----]. That's where we are rn with no Medicare coverage and [--] reps"  
[X Link](https://x.com/Michigan_Value/status/1828152612904149327)  2024-08-26T19:28Z [---] followers, [----] engagements


"@bsg_cap How about: Management well known to be mistake prone; One never knows for sure about clinical trials. After the run up share price was cheap only if the trial went well and only if management didn't destroy value. FWIW these are the reasons I passed on @MOB.ST"  
[X Link](https://x.com/Michigan_Value/status/1835081371754123649)  2024-09-14T22:21Z [---] followers, [---] engagements


"@PedroLamento Craig at $CPH.TO is actually pretty smart as far as I can tell. He will almost certainly make a rational decision here imho. Also Cipher is up 3x over the last year as you are well aware. I think Craig's PA is juuuust fine ;-)"  
[X Link](https://x.com/Michigan_Value/status/1835705503860547694)  2024-09-16T15:41Z [---] followers, [----] engagements


"Have people heard the argument that if the Fed lowers rates [--] bps it will spook the market bc people will think the Fed "knows something" Does anyone actually believe the Fed knows anything"  
[X Link](https://x.com/Michigan_Value/status/1835716380106076273)  2024-09-16T16:24Z [---] followers, [---] engagements


"When everything is fine the Fed is supposed to set rates at neutral. Neutral is maybe 3-3.5%. The Fed thinks the economy is fine and inflation is in check so they are moving to neutral. Why is this confusing"  
[X Link](https://x.com/Michigan_Value/status/1836743201006158257)  2024-09-19T12:24Z [---] followers, [---] engagements


"@Russell_A1221 The Fed has done some odd things. But this move to normalize seems anything but odd right"  
[X Link](https://x.com/Michigan_Value/status/1836743834383888772)  2024-09-19T12:27Z [---] followers, [--] engagements


"@LukeWolgram nah dead wrong. find the best stock ideas you can and they are what they are. You can't specifically pick ahead of time to "find doubles" vs finding [--] baggers. And btw if one does find a few ten bagger potential stocks often some of them don't work out 10x but wind up 2x"  
[X Link](https://x.com/Michigan_Value/status/1837501562941231261)  2024-09-21T14:38Z [---] followers, [---] engagements


"$HROW Vevye and $MOB.TO $CPH.TO MOB-015 are similar. Clinical trial data great active ingredient well known efficacy better delivery vehicle. Most patients don't treat disease bc legacy drugs suck. Market share but also they will grow the market"  
[X Link](https://x.com/Michigan_Value/status/1838235657157697985)  2024-09-23T15:15Z [---] followers, [----] engagements


"$MOB.ST comrades: does everyone understand why a MOB-15 study with an extended observation period after treatment would fail There's a reason it would. Here's the thing. A nail that has a myco cure winds up with fungus again 50% of the time. Did you guys know that"  
[X Link](https://x.com/Michigan_Value/status/1838287492761497903)  2024-09-23T18:41Z [---] followers, [----] engagements


"And whether this is a relapse or reinfection who knows. Could be the fungus is still there but suppressed to the point the test can't detect it. And it could be that people don't change their sox and the fungus comes back. Either way a 76% myco cure = 38% for real cure"  
[X Link](https://x.com/Michigan_Value/status/1838287494133190990)  2024-09-23T18:41Z [---] followers, [---] engagements


"MOB was hoping that a lower dosage 1x/wk of MOB-015 would be enough to finish treatment and prevent recurrence after initial [--] weeks at 1x/day. But it isn't. Whiteness maybe related to nail porosity And w/o porosity terbinafine sits on the outside of the nail useless"  
[X Link](https://x.com/Michigan_Value/status/1838287497778094519)  2024-09-23T18:41Z [---] followers, [---] engagements


"Best move imho Just sell it as is. Tell people it gets a 76% myco cure and let them decide if they want it. I like their chances. If I had nagelsvamp - my new favorite word - I would def use it. Import it from Sweden if need be. Where btw MOB-015 is killing it"  
[X Link](https://x.com/Michigan_Value/status/1838287500156260696)  2024-09-23T18:41Z [---] followers, [---] engagements


"And then from there. maybe come up with a study to extend the patent. That would be valuable if they can think of a way. But first sell it. Gotta sell it and get some cash flow"  
[X Link](https://x.com/Michigan_Value/status/1838287502656061625)  2024-09-23T18:41Z [---] followers, [---] engagements


"People really don't understand just how big this is going to be. So many models I see are just delusional. 3e has a J code demand is through the roof price is $944 before discounting. 90k units produced already some of which were used in testing. They will sell all units"  
[X Link](https://x.com/Michigan_Value/status/1838628217868968119)  2024-09-24T17:15Z [---] followers, [---] engagements


"@PythiaR Which is a pass on the litmus test owning it or failing to own it"  
[X Link](https://x.com/Michigan_Value/status/1838628825791397919)  2024-09-24T17:17Z [---] followers, [---] engagements


"The first was $NXST in [----] a nice 30x ride since then. Guys it's amazing what even one of these does for performance a "Black Swan" that works in one's favor. They can be found. I keep preaching but like some Bizzarro Cassandra I convince almost no one"  
[X Link](https://x.com/Michigan_Value/status/1838661826424508705)  2024-09-24T19:28Z [---] followers, [---] engagements


"@Russell_A1221 That's it Hansen natural. Looked at it and passed. so dumb. Also I talked my friend out of Apple in [----]. So many mistakes. Hard to imagine how I could have been so dumb and still wind up doing so well"  
[X Link](https://x.com/Michigan_Value/status/1838666530998866045)  2024-09-24T19:47Z [---] followers, [---] engagements


"$MOB.ST's whitening effect is water in the nail. Likely aids in transporting terbinafine from the nail surface to under the nail. This may be why the vehicle works. No need to overthink where water comes from. It's in the air human skin sweat and people get their toes wet"  
[X Link](https://x.com/Michigan_Value/status/1839316975262249283)  2024-09-26T14:51Z [---] followers, [----] engagements


"@SebKrog I sure as heck hope he is strategic about it since I am long $CPH.TO. Either way I think he might be. It seems clear MOB-15 will sell well to me anywhere but Japan where it's likely DOA. I think Craig knows that and is smart and there's no reason not to press the advantage"  
[X Link](https://x.com/Michigan_Value/status/1839334072273002891)  2024-09-26T15:59Z [---] followers, [---] engagements


"@illyquid @SebKrog Jublia is deeply entrenched and regulators are fixated on "complete cure" rates. Prolly can't convince them"  
[X Link](https://x.com/Michigan_Value/status/1839335492061638942)  2024-09-26T16:05Z [---] followers, [---] engagements


"@PythiaR It's a fair point. It's also fair to point out that MOB raised a lot of cash when the share price was higher. That cash on the balance sheet may be the main reason MOB shareholders aren't down LTM Agree the story is far from over though"  
[X Link](https://x.com/Michigan_Value/status/1840361975601037680)  2024-09-29T12:04Z [---] followers, [---] engagements


"And that's it"  
[X Link](https://x.com/Michigan_Value/status/1840389244813992090)  2024-09-29T13:52Z [---] followers, [----] engagements


"@ReganCoda That's unkind. Also those stocks have done alright. TTM $CPH.TO up 240% $MOB.ST up 50%. Big drop recently I'll give you that"  
[X Link](https://x.com/Michigan_Value/status/1840425738689724862)  2024-09-29T16:17Z [---] followers, [---] engagements


"@PythiaR well sure. I answered the question but I haven't spelled out the details for you. The full analysis is more thoughtful but I will not be posting it on twitter. As an aside you have my all time favorite handle. Well done"  
[X Link](https://x.com/Michigan_Value/status/1840470221418819816)  2024-09-29T19:14Z [---] followers, [---] engagements


"@ReplyGuy_Cap @PedroLamento @PythiaR Oh I want to be VERY clear that the game is not over. M15 will sell well imho and I hope to profit from it. Fortunately for me I avoided the recent challenges. I think people might be interested in the reasoning hence the post. But where things go from here remains to be seen"  
[X Link](https://x.com/Michigan_Value/status/1840735576972009768)  2024-09-30T12:48Z [---] followers, [---] engagements


"Reposting this from 9/23 to highlight my POV on m15. You guys all hopefully know how bullish I am on Vevye at $HROW so hopefully this clears things up for anyone confused on what I have said in the past about m15"  
[X Link](https://x.com/Michigan_Value/status/1840779140783337534)  2024-09-30T15:42Z [---] followers, [---] engagements


"@ChrisOlin @PedroLamento Anna is imperfectly aligned with shareholder of $MOB.ST. That is true. I would expect some effort will be made to keep management's salaries safe. Clearly enough cash on the balance sheet rn to pay management for many years to come however. A raise is not needed just for that"  
[X Link](https://x.com/Michigan_Value/status/1840836796722143238)  2024-09-30T19:31Z [---] followers, [---] engagements


"@PedroLamento @ChrisOlin Honestly that's just awesome. Love the passion It would be better to have an easy path to full insurance coverage but the other side is that the product works so well. FWIW my guess is m15 gets monetized in the US. but we shall see"  
[X Link](https://x.com/Michigan_Value/status/1842173398849376621)  2024-10-04T12:02Z [---] followers, [---] engagements


"Compounding is a different. Customers tell $HROW what they are looking for. For branded drugs a company has a drug and tries to sell it. But in compounding the customers tell you what they are looking for. For the right CEO this insight could prove valuable. Moat"  
[X Link](https://x.com/Michigan_Value/status/1842921592495714472)  2024-10-06T13:35Z [---] followers, [---] engagements


"And I met CEO Baum. Very smart and totally obsessed with $HROW. People like Mark can be insanely driven to build the company that they love. I've known people like this. They literally truly love the company they build some of them. Can you think of any founders like that"  
[X Link](https://x.com/Michigan_Value/status/1842921594601222493)  2024-10-06T13:35Z [---] followers, [---] engagements


"@TrentBlair19 Well obviously would have been Mark Baum at $HROW but not sure it's still a microcap now that it's up so much"  
[X Link](https://x.com/Michigan_Value/status/1843708892301402125)  2024-10-08T17:43Z [---] followers, [---] engagements


"@Divergent7651 It says something positive about the moat around the business. Most management can't afford to give away critical pricing information to their competition. $AZO doesn't have to care about competition much so this is fine. For a different business with less moat not so much"  
[X Link](https://x.com/Michigan_Value/status/1843986208785068539)  2024-10-09T12:05Z [---] followers, [---] engagements


"True lollapalooza potential in small cap pharma. Not just $HROW $CPH.TO. Well managed companies can be bought by investors at low prices AND management can acquire products like Natroba Vevye and 3e for a song = lollapalooza. I'm up 5x YTD24. Will be way up in [----] too"  
[X Link](https://x.com/Michigan_Value/status/1844377942039855189)  2024-10-10T14:02Z [---] followers, [----] engagements


"Crappy companies like $BLCO with poor management make bad acquisitions and pass on the good stuff. One has to be able to tell the difference. But for an investor that can It's a frickin' golden age"  
[X Link](https://x.com/Michigan_Value/status/1844377943684022545)  2024-10-10T14:02Z [---] followers, [---] engagements


"@PedroLamento Yup nailed it imho. 1/wk maintenance either 1) doesn't whiten & doesn't make the nail porous to terb; or 2) does both. This makes aesthetic cure labeling tricky even tho the drug excels at killing fungus. No easy trial design but m15 works & people want it. That matters"  
[X Link](https://x.com/Michigan_Value/status/1845066435460022396)  2024-10-12T11:38Z [---] followers, [----] engagements


"$HROW isn't always rationally traded @Montrea92285044"  
[X Link](https://x.com/Michigan_Value/status/1846636930769080802)  2024-10-16T19:38Z [---] followers, [---] engagements


"@ChrisOlin This is so funny"  
[X Link](https://x.com/Michigan_Value/status/1846985531286344133)  2024-10-17T18:44Z [---] followers, [---] engagements


"@PythiaR ok thanks"  
[X Link](https://x.com/Michigan_Value/status/1847249597506146709)  2024-10-18T12:13Z [---] followers, [---] engagements


"@ttril22 well these sorts of things come along infrequently. The last was [--] years ago when I bought $NXST for $6 and change [--] bagger since. Then $HROW. It might be another [--] years before I find another one"  
[X Link](https://x.com/Michigan_Value/status/1847313312272285741)  2024-10-18T16:26Z [---] followers, [---] engagements


"@PedroLamento Sheesh you and I must have very different definitions of what a shitco is"  
[X Link](https://x.com/Michigan_Value/status/1848722248082821398)  2024-10-22T13:45Z [---] followers, [---] engagements


"@PedroLamento $CPH.TO is a well managed non-cyclical company with a moat positive FCF modest debt and excellent growth prospects. That's the opposite of a shitco"  
[X Link](https://x.com/Michigan_Value/status/1848723259879018819)  2024-10-22T13:49Z [---] followers, [---] engagements


"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfmAI=Triamcinolone%20Acetonide%20Injection&st=c https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfmAI=Triamcinolone%20Acetonide%20Injection&st=c"  
[X Link](https://x.com/Michigan_Value/status/1849504781309550839)  2024-10-24T17:34Z [----] followers, [---] engagements


"@marketplunger1 Sure. Best guess you are only considering $PTON bc Einhorn pump. He did some solid work a long time ago but has kinda sucked for a while. You'd be paying up compared to recent prices. You may not know much about it. you did call it "a flyer". Always a red flag. Does that help"  
[X Link](https://x.com/Michigan_Value/status/1849815836908806584)  2024-10-25T14:10Z [----] followers, [---] engagements


"$HROW new IQVIA data shows Iheezo running 17k units/month or about $18.5M per quarter of net revenue to HROW @$366 (not WAC). Retina just now taking off. Iheezo [----] $100M+ revenue slam dunk at this point"  
[X Link](https://x.com/Michigan_Value/status/1851308325545123994)  2024-10-29T17:01Z [----] followers, [----] engagements


"My $MOB.ST journey: Normally a Swedish microcap would be off my radar but Moberg was discovered by a colorful group on Twitter. And there was some good work that they did and they got some things really really right. They were right about m15 that's for sure"  
[X Link](https://x.com/Michigan_Value/status/1858542978932867232)  2024-11-18T16:09Z [---] followers, [----] engagements


"@FelixSchreibe13 @gasparespontin1 Wait you don't want to discuss how I'm up 70% on Moberg in a couple months And 5x YTD overall I guess I'm the idiot you're the genius. Point taken and thanks for putting me in my place 😆"  
[X Link](https://x.com/Michigan_Value/status/1858547028696932697)  2024-11-18T16:25Z [---] followers, [---] engagements


"@arbiter_jack Think through what you just said and then answer your own question"  
[X Link](https://x.com/Michigan_Value/status/1858592139648655362)  2024-11-18T19:24Z [---] followers, [---] engagements


"@Michael15107053 My grandma used to say "If wishes were horses beggars would ride". Feel free to wish but $HROW is likely the buyer"  
[X Link](https://x.com/Michigan_Value/status/1858592480100323618)  2024-11-18T19:25Z [---] followers, [---] engagements


"$MOB.ST [----] m15 EU launch probable more than $0.50 pre-tax FCF/sh coming in the EU alone. Already in Sweden huge success right away. No debt $0.60/share of cash $1/sh milestone payments coming. Stock at $1.50. Likely more launches in US and RoW. Too cheap"  
[X Link](https://x.com/Michigan_Value/status/1858852585614004366)  2024-11-19T12:39Z [---] followers, [----] engagements


"@WallStPirate The milestone is additional payments from Bayer to Moberg if certain objectives are met. Details are not known but milestone payments are common. Only Sweden launched in [----] half the EU launches in Q1 [----] the rest hopefully soon after"  
[X Link](https://x.com/Michigan_Value/status/1858858717036396905)  2024-11-19T13:03Z [---] followers, [---] engagements


"@kneesovertoesg I will never dunk but my knees are in great shape now. Thanks"  
[X Link](https://x.com/Michigan_Value/status/1858954720892878968)  2024-11-19T19:25Z [---] followers, [---] engagements


"@winsteadscap Weird daydream. Imagining oneself in the major leagues. and hitting a single with no one on. The crowd politely applauds"  
[X Link](https://x.com/Michigan_Value/status/1858957517365113259)  2024-11-19T19:36Z [---] followers, [----] engagements


"$ATKR numbers just not good at all but actually about where I would have put them a few years ago if not for them telling us to expect so much better. I had such confidence in mgmt guidance that I replaced my own estimate with theirs. I really blew it there. My bad"  
[X Link](https://x.com/Michigan_Value/status/1859583092312138213)  2024-11-21T13:02Z [---] followers, [----] engagements


"$BRKB People don't realize just how good Warren Buffett was. They think they do but they don't"  
[X Link](https://x.com/Michigan_Value/status/1861434944058208615)  2024-11-26T15:40Z [---] followers, [---] engagements


"Um no one thinks there's any chance of anything other than a failed US phase [--] trial for $MOB.ST right The company was pretty clear about this. I would think it was already in the market but maybe some people don't know"  
[X Link](https://x.com/Michigan_Value/status/1864041039968768459)  2024-12-03T20:16Z [---] followers, [----] engagements


"$MOB.ST m15 US phase3 trial will fail to meet its primary endpoint according to Moberg. Yet some people think it trades down when the trial reads out. Is this likely I am fascinated by the prospect & stand ready to profit. But is anyone really that dumb"  
[X Link](https://x.com/Michigan_Value/status/1864294898788147556)  2024-12-04T13:05Z [---] followers, [----] engagements


"$HROW how can anyone look at this and not be impressed Other than by being dumb I mean"  
[X Link](https://x.com/Michigan_Value/status/1865134620481655082)  2024-12-06T20:42Z [---] followers, [----] engagements


"$MOB.ST was all set to launch OTC in the US. Had all their ducks in a row. Just needed that US clinical trial to be "good enough" for FDA approval. Whoever said OTC in the US couldn't be done was flat out wrong"  
[X Link](https://x.com/Michigan_Value/status/1867259661281636775)  2024-12-12T17:26Z [---] followers, [----] engagements


"The logic for this trial imho: whitening begins in earnest at [--] wks. [--] wks daily and then weekly = overkill if linear response. Extending past [--] wks = more whitening but more myco. Would [--] or [--] be better apriori No way to know"  
[X Link](https://x.com/Michigan_Value/status/1867287591617192229)  2024-12-12T19:17Z [---] followers, [---] engagements


"So they tried something reasonable and tested it. Experiment is how science works. If it worked they would have extended the patent and launched Rx in the US. If it worked less well they could launch OTC in the US. Not crazy but didn't work"  
[X Link](https://x.com/Michigan_Value/status/1867287592653205848)  2024-12-12T19:17Z [---] followers, [---] engagements


"And for those who think they know a better trial well if one is willing to settle for OTC in the US then yes. Just redo the Europe trial. For a US Rx launch you need something clever like what they did but which works"  
[X Link](https://x.com/Michigan_Value/status/1867287593924296804)  2024-12-12T19:17Z [---] followers, [---] engagements


"@miamimike999 I don't think I am in a position to say for sure whether the trial was optimal given what was known. As far as I can tell it was a reasonable trial design if the goal was to launch Rx in the US and extend the patent"  
[X Link](https://x.com/Michigan_Value/status/1867321213103853940)  2024-12-12T21:30Z [---] followers, [---] engagements


"@NerdcapK yes. they need another phase [--] trial to satisfy the FDA. And that costs time and money and then the launch itself would require management attention that they have decided to devote to the EU. It might happen but it's not simple imho"  
[X Link](https://x.com/Michigan_Value/status/1867321717384986865)  2024-12-12T21:32Z [---] followers, [--] engagements


"$HROW blog post. It's free. https://seekingalpha.com/instablog/213542-michigan-value-investor/6098014-graph-of-hrows-40-percent-revenue-cagr https://seekingalpha.com/instablog/213542-michigan-value-investor/6098014-graph-of-hrows-40-percent-revenue-cagr"  
[X Link](https://x.com/Michigan_Value/status/1867938271785038050)  2024-12-14T14:22Z [---] followers, [----] engagements


"@bioturds That's what people said about $AMZN for all those years ;-)"  
[X Link](https://x.com/Michigan_Value/status/1869366339791655312)  2024-12-18T12:57Z [---] followers, [--] engagements


"Given that trials fail all the time who would ever develop a drug if it's a loser even when the results are great. And yet that's how $MOB.ST trades. As if the drug itself is of little value. They have $0.65/share in cash and trade for $1"  
[X Link](https://x.com/Michigan_Value/status/1869398456374370661)  2024-12-18T15:04Z [---] followers, [---] engagements


"$HROW blog post. It's free. https://seekingalpha.com/instablog/213542-michigan-value-investor/6100060-hrows-stock-price-is-volatile-business-isnt https://seekingalpha.com/instablog/213542-michigan-value-investor/6100060-hrows-stock-price-is-volatile-business-isnt"  
[X Link](https://x.com/Michigan_Value/status/1869816354402083193)  2024-12-19T18:45Z [---] followers, [----] engagements


"@JoeBotticelli Imagine thinking Moberg sells products at a loss. I don't know what to say to this exactly. how about "capitalism isn't like that" Some people think it should be but no it's not"  
[X Link](https://x.com/Michigan_Value/status/1869817064342597639)  2024-12-19T18:48Z [---] followers, [---] engagements


"$HROW's Iheezo data. No need to over react to one week and note that end of Q sales always tick way up. On track for $100M Iheezo in [----]. Will Iheezo exceed Vevye in [----] Tough call. Vevye also tracking to $100M in [----]. Either may inflect"  
[X Link](https://x.com/Michigan_Value/status/1875194462282141849)  2025-01-03T14:56Z [---] followers, [----] engagements


"$HROW any heroes out there care to share the latest IQVIA data 🙏"  
[X Link](https://x.com/Michigan_Value/status/1887535350009966721)  2025-02-06T16:14Z [---] followers, [----] engagements


"Some really big news coming at $HROW. Can hardly believe what I am hearing"  
[X Link](https://x.com/Michigan_Value/status/1894059789019177449)  2025-02-24T16:20Z [---] followers, [----] engagements


"$HROW guiding [----] EBITDA way up as a % of revenue and 40% revenue growth. In [----] EBITDA was negative. Is this trend good"  
[X Link](https://x.com/Michigan_Value/status/1915451554682884193)  2025-04-24T17:03Z [---] followers, [----] engagements


"$HROW $ETON imagine actually understanding the businesses comparing to the price and making investment decisions on that basis and making tons of $. Sound impossible It's actually not even hard"  
[X Link](https://x.com/Michigan_Value/status/1925239576030798219)  2025-05-21T17:17Z [----] followers, [----] engagements


"$ALC's Tryptyr or $HROW's Vevye Tryptyr treats dry eye disease - causing pain on installation in 50% of patients - by helping tear formation. So the drug that causes pain also causes tears. Anyone else see a connection Vevye works better and doesn't hurt so"  
[X Link](https://x.com/Michigan_Value/status/1930608337596400104)  2025-06-05T12:51Z [----] followers, [----] engagements


"will run higher if revenue ramps from here. But one needs to understand why there was extra spending in [----] compared to [----] in order to do that which ofc I do and it's not hard to understand. But that aside just looking at the data itself these are clearly up and to the"  
[X Link](https://x.com/Michigan_Value/status/1943405123931378018)  2025-07-10T20:21Z [---] followers, [---] engagements


"right over the last [--] years. There's zero doubt about that. Small cap pharma companies always burn cash during the ramp of new drug launches. HROW is able to be FCF neutral during this phase - very unusual - because the legacy business is generating enough cash to offset these"  
[X Link](https://x.com/Michigan_Value/status/1943405125785047544)  2025-07-10T20:21Z [---] followers, [---] engagements


"losses. The way it usually works in small cap pharma is that the new drug burns cash early on and then if it's successful - this is the big if - but IF it ramps THEN it becomes a FCF machine. My only claim about HROW on this front is that it's the same for them as for every"  
[X Link](https://x.com/Michigan_Value/status/1943405127827698005)  2025-07-10T20:21Z [---] followers, [---] engagements


"other new drug launch. Iheezo and Triesence and Vevye all burn cash for a while but then if they ramp they will generate cash. They launched Iheezo in [----] and then Vevye and Triesence in [----]. This is very early in the process and even without interest expense this *should* be"  
[X Link](https://x.com/Michigan_Value/status/1943405129245307215)  2025-07-10T20:21Z [---] followers, [---] engagements


"a negative FCF time for them. But the rest of the business generates cash pays the interest and offsets the new launch cash burn. HROW also spends a lot less when launching drugs than other companies. They can get away with this - if they can let's see if they really do ramp as"  
[X Link](https://x.com/Michigan_Value/status/1943405130616799422)  2025-07-10T20:21Z [---] followers, [---] engagements


"much as I hope they do - because of the existing distribution from the legacy company. That's the part that makes HROW different. It's that they built a distribution company using the legacy compounding business. The new launches still burn cash until/unless they ramp just not"  
[X Link](https://x.com/Michigan_Value/status/1943405132261020076)  2025-07-10T20:21Z [---] followers, [---] engagements


"as much as a regular small cap pharma. This ability to launch efficiently is also why they are able to buy drugs so cheaply and pay the sellers with royalties. HROW can launch Iheezo and Vevye and now Byqlovi and soon Melt with much higher odds of success and at a much lower cost"  
[X Link](https://x.com/Michigan_Value/status/1943405133729271879)  2025-07-10T20:21Z [---] followers, [---] engagements


"than the previous owners could so those folks sell to HROW for almost nothing up front and hope for royalties. An added bonus for HROW shareholders is that the legacy business is scaled sufficiently now to actually generate cash so the cash burn from the new launches is offset"  
[X Link](https://x.com/Michigan_Value/status/1943405135264153643)  2025-07-10T20:21Z [---] followers, [---] engagements


"by cash generated by the legacy business. This is what makes HROW different than some random small cap pharma with a drug that may or may not ramp. They operate at zero FCF during their initial drug launches. Then if these do ramp (this is the part we don't know IF they ramp)"  
[X Link](https://x.com/Michigan_Value/status/1943405136522424480)  2025-07-10T20:21Z [---] followers, [---] engagements


"New public $HROW article. It's free. https://seekingalpha.com/article/4800763-harrow-internal-100-target-ambitious-new-bloomberg-data-backs-it https://seekingalpha.com/article/4800763-harrow-internal-100-target-ambitious-new-bloomberg-data-backs-it"  
[X Link](https://x.com/Michigan_Value/status/1943810235165970888)  2025-07-11T23:10Z [----] followers, [----] engagements


"@TOWiU2 it means they sold a lot more drug. Bloomberg is reporting June Vevye WAC of $41M compared to $23M in March for example. WAC excludes rebates and discounts so the actual revenue to $HROW is less. But everything else equal 4123"  
[X Link](https://x.com/Michigan_Value/status/1944020396816138474)  2025-07-12T13:05Z [---] followers, [---] engagements


"$HROW imagine being so dumb you could look at this graph of EBITDA margins and conclude there's zero operating leverage in the business. You literally can't"  
[X Link](https://x.com/Michigan_Value/status/1944045167213699521)  2025-07-12T14:44Z [---] followers, [----] engagements


"Dip in [----] margins was due to heavy spending sorting out manufacturing issues for 3e (very tricky) and launch costs for two new drugs Vevye and 3e compared to one Iheezo in 2023"  
[X Link](https://x.com/Michigan_Value/status/1944045168987922531)  2025-07-12T14:44Z [---] followers, [---] engagements


"BTIG headline today: "Samsung Bioepis Deal Is a Good Example of the Reason to Own Harrow. With the Pieces in Place They Can Make Money Where Others Can't" Even sell side starting to understand $HROW's business model. ALMOST as if they read MVI articles 🤣"  
[X Link](https://x.com/Michigan_Value/status/1945914417083826358)  2025-07-17T18:32Z [---] followers, [----] engagements


"@app_hyd https://investors.harrow.com/news-releases/news-release-details/harrow-names-greg-dipasquale-senior-vice-president-head https://investors.harrow.com/news-releases/news-release-details/harrow-names-greg-dipasquale-senior-vice-president-head"  
[X Link](https://x.com/Michigan_Value/status/1945935507801637085)  2025-07-17T19:55Z [---] followers, [---] engagements


"$HROW new article inside my pay service"  
[X Link](https://x.com/Michigan_Value/status/1945947748131291169)  2025-07-17T20:44Z [----] followers, [----] engagements


"You guys get the difference between founder CEOs and um the other guys right Think of examples of caretaker CEOs who've really killed it. Now tell me about the founder CEOs who have. See what I mean Get them early and 100x. Mark Baum $HROW will be 100x for me"  
[X Link](https://x.com/Michigan_Value/status/1946226085118583079)  2025-07-18T15:10Z [----] followers, [----] engagements


"@TOWiU2 @app_hyd dude Greg works at $HROW. Make it a question instead of a statement the next time you're confused https://www.linkedin.com/in/greg-dipasquale-016526a/ https://www.linkedin.com/in/greg-dipasquale-016526a/"  
[X Link](https://x.com/Michigan_Value/status/1947449944563990818)  2025-07-22T00:13Z [----] followers, [---] engagements


"one can quibble with those numbers but the TAM easily supports quite a bit more they are growing super fast and are very much on track. They're as likely to hit over as under imho but quibble as you see fit it won't matter"  
[X Link](https://x.com/Michigan_Value/status/1949892584265933086)  2025-07-28T17:59Z [----] followers, [----] engagements


"Next let's consider the [--] new drugs acquired for almost nothing up front. $HROW's M&A terms: 10% royalties and zilch up front. Small drug companies take the deal bc HROW can sell those drugs way better than the original owners can. Those [--] drugs likely another $300M include"  
[X Link](https://x.com/Michigan_Value/status/1949892585805221995)  2025-07-28T17:59Z [---] followers, [----] engagements


"Byqlovi and biosimilars for Lucentis and Eylea. Byqlovi competes with a [----] drug that had $165M in [----] despite having a generic and Byqlovi is a brand new better drug. The Lucentis biosimilar did $36M in [----] despite being early days the Eylea one launches soon"  
[X Link](https://x.com/Michigan_Value/status/1949892587520655756)  2025-07-28T17:59Z [---] followers, [---] engagements


"We are at $1.95B. $HROW will almost certainly acquire Melt a $1B+ potential drug over time though it will be well into the 2030's to get there. By [----] maybe $200m or $300M And they will acquire more and more drugs"  
[X Link](https://x.com/Michigan_Value/status/1949892589202686329)  2025-07-28T17:59Z [---] followers, [---] engagements


"Why would anyone doubt they will acquire more And not by issuing debt or equity or depleting the balance sheet. No they will offer nothing up front and the sellers will take a royalty. Let's look at the track record so far:"  
[X Link](https://x.com/Michigan_Value/status/1949892590905483412)  2025-07-28T17:59Z [---] followers, [---] engagements


"2023 Iheezo $300M drug $8M + 5% royalty [----] Vevye $1B drug $8M + 12% royalty [----] Byqlovi&biosimilars $300M drugs $1.6M + royalty tbd 2025/26 Melt ophthalmic $300M drug terms tbd"  
[X Link](https://x.com/Michigan_Value/status/1949892592696528982)  2025-07-28T17:59Z [---] followers, [---] engagements


"ok Melt hasn't happened yet but so far in [--] years that's [--] drugs that likely hit $1.6B for less than $20M up front. [----] isn't even over yet. Let's think that through shall we"  
[X Link](https://x.com/Michigan_Value/status/1949892594420338737)  2025-07-28T17:59Z [---] followers, [---] engagements


"We are already at $2.25B in [----] including Melt. But there will be more. Another $300M/yr $500M/yr Decent chance by [----] they add another $2B on top of what they have So. How exactly are they not getting to $2B"  
[X Link](https://x.com/Michigan_Value/status/1949892596119024080)  2025-07-28T17:59Z [---] followers, [---] engagements


"$HROW website now updated to look like it's not [--] years old: https://investors.harrow.com/ https://investors.harrow.com/"  
[X Link](https://x.com/Michigan_Value/status/1950653280801165711)  2025-07-30T20:22Z [----] followers, [----] engagements


"$IONQ Chris Monroe explicitly says quantum computing is at peak hype & predicts a "trough of disillusionment". Good short"  
[X Link](https://x.com/Michigan_Value/status/1951725465372094830)  2025-08-02T19:23Z [----] followers, [----] engagements


"$ALC great at selling. New MoA for Tyrvaya = convince some doctors it's better for some patients. Expect nonsense posts by doctors like we saw with Miebo explaining the "science" they learned from reps. But Tyrvaya burns on installation. People hate when their eyes burn"  
[X Link](https://x.com/Michigan_Value/status/1952715391890853939)  2025-08-05T12:56Z [----] followers, [---] engagements


"Consider Increlex bought from Ipsen for peanuts. Ipsen is too big for this drug. [---] patients a few years ago down to [--] Q4 [----]. [--] months as part of ETON and patient count [---] and heading up. But it gets waaaay better"  
[X Link](https://x.com/Michigan_Value/status/1953828722240360742)  2025-08-08T14:40Z [----] followers, [---] engagements


"There are only [---] qualified patients in the US. Need to be [--] sd low IGF-1. Europe standard [--] sd. ETON study to match this standard. Zero doubt - none - that patients benefit. Vulnerable children. If approved [----] patients $300M revenue 4x [----] ETON total revenue"  
[X Link](https://x.com/Michigan_Value/status/1953828723905507597)  2025-08-08T14:40Z [----] followers, [---] engagements


"That would never have happened on Ipsen's watch. ETON specializes in it. Increlex only one example. This will happen again and again and again with drugs in the pipeline already and with more M&A. Stock at $15 heading well north of $100. People don't get it yet but they will"  
[X Link](https://x.com/Michigan_Value/status/1953828725595721848)  2025-08-08T14:40Z [----] followers, [---] engagements


"@niubi1988 are you mad bc I am making fun of $TSLA or bc you think that post was serious"  
[X Link](https://x.com/Michigan_Value/status/1954523542424310065)  2025-08-10T12:41Z [----] followers, [--] engagements


"$HROW missed expectations of $66M revenue in the quarter with $64M. The miss is due to $5M in Other Specialty instead of the expected $10M. Other Specialty is filled with volatile no growth legacy products which are irrelevant"  
[X Link](https://x.com/Michigan_Value/status/1955264904274866209)  2025-08-12T13:47Z [----] followers, [----] engagements


"$HROW down today bc Vevye revenue declined and Other Specialty (OS) came in $5M light. OS is volatile legacy drugs and nearly meaningless long term. Might be $5M higher next Q who cares. Vevye revenue recognition items shift revenue Q to Q. Vevye corrected for GAAP artifacts:"  
[X Link](https://x.com/Michigan_Value/status/1955323837890900443)  2025-08-12T17:41Z [----] followers, [----] engagements


"$HROW article on my pay service:"  
[X Link](https://x.com/Michigan_Value/status/1955333509892997217)  2025-08-12T18:20Z [----] followers, [----] engagements


""beat" vs "miss" = lame. Imagine being dumb enough to care about a "beat" for economic reasons. Short term I care bc dummies trade on it. It's highly reflexive. Smart people can care about how dumb people will react. That's the ONLY reason to care about a "beat". Re/ $HROW would"  
[X Link](https://x.com/Michigan_Value/status/1956425375233581390)  2025-08-15T18:38Z [----] followers, [---] engagements


"anyone prefer $HROW came in at $70M on a "beat" but only because Immy shockingly outperformed expectations and the Fab [--] recovered to [----] levels but Iheezo and Vevye were tepid"  
[X Link](https://x.com/Michigan_Value/status/1956425376923549990)  2025-08-15T18:38Z [----] followers, [---] engagements


"7) Possible shift in market's view on management. IR vastly improved and doubters increasingly look stupid - not just wrong but stupid - and business & stock performance combined with management's "never sell a share" attitude begets fandom"  
[X Link](https://x.com/Michigan_Value/status/1956429391065423983)  2025-08-15T18:54Z [----] followers, [----] engagements


"$HROW $100 is coming. Should be sharply higher by Q3 [----] earnings and then $100 maybe before year end or maybe after Q4 [----] earnings. But $100 coming. And lots more after that"  
[X Link](https://x.com/Michigan_Value/status/1956429392738959808)  2025-08-15T18:54Z [----] followers, [----] engagements


"@zipjet you're welcome But it won't be 150% yoy. It's $100M Q4 [----] and then $250M Q4 2027"  
[X Link](https://x.com/Michigan_Value/status/1956717529667453130)  2025-08-16T13:59Z [----] followers, [--] engagements


"Plainly obvious that $HROW ttm leverage when they announce Q4 [----] earnings will be 2x forward leverage will be 1x and by YE [----] HROW will be unlevered unless there's some big buyback or special dividend or something. Everyone can see this right"  
[X Link](https://x.com/Michigan_Value/status/1957539157296755184)  2025-08-18T20:24Z [----] followers, [----] engagements


"$NXST article out today"  
[X Link](https://x.com/Michigan_Value/status/1961480010436317646)  2025-08-29T17:24Z [----] followers, [---] engagements


"$HROW Apparently Xiidra feels like lemon juice compared to Vevye or Miebo. The new DED drugs hurt less and work better. Especially Vevye"  
[X Link](https://x.com/Michigan_Value/status/1963710406398198117)  2025-09-04T21:06Z [----] followers, [----] engagements


"I heard Xavier Worthy was injured and thought the obvious question any one would I wonder if his dad is the great @JamesWorthy42 & this is what Google's AI delivered:"  
[X Link](https://x.com/Michigan_Value/status/1964385889137889558)  2025-09-06T17:51Z [----] followers, [----] engagements


"@finnishboycp @TOWiU2 More M&A is coming. It really is. The biosimilars they just bought are $80M/yr - per point - of market share. $HROW lowest cost distribution structure. Think about that advantage for a moment. Before biosimilars were Vevye and Iheezo. Melt is coming and more after that"  
[X Link](https://x.com/Michigan_Value/status/1964414007239987542)  2025-09-06T19:42Z [----] followers, [---] engagements


"More M&A is coming. It really is. The biosimilars they just bought are $80M/yr - per point - of market share. $HROW lowest cost distribution structure. Think about that advantage for a moment. Before biosimilars were Vevye and Iheezo. Melt is coming $1B+ and more after that"  
[X Link](https://x.com/Michigan_Value/status/1964416272784855536)  2025-09-06T19:51Z [----] followers, [----] engagements


"Another great interview today on CNBC with Dr. Marty Makary $HROW board member until he left Jan [--] [----] to run the FDA for the Trump administration. Anyone who thinks HROW will be surprised by new pharma policies might want to reflect on this"  
[X Link](https://x.com/Michigan_Value/status/1965822258175475975)  2025-09-10T16:58Z [----] followers, [----] engagements


"Also anyone who thinks $HROW is somehow not a serious company might want to ask themselves why the sitting FDA commissioner was on its board"  
[X Link](https://x.com/Michigan_Value/status/1965826642401702239)  2025-09-10T17:16Z [----] followers, [---] engagements


"BBG Iheezo data = low quality; Q2 BBG 35k units vs 49k actual. FWIW they have Iheezo flat in August but caveat emptor on that"  
[X Link](https://x.com/Michigan_Value/status/1966526612112867443)  2025-09-12T15:37Z [----] followers, [---] engagements


"$HROW investor day agenda: pivot to #crypto / #AI ophthalmology CYCLO-COIN and VEVY-AI: https://www.harrow.com/news-releases/news-release-details/harrow-announces-agenda-and-speakers-investor-analyst-day https://www.harrow.com/news-releases/news-release-details/harrow-announces-agenda-and-speakers-investor-analyst-day"  
[X Link](https://x.com/Michigan_Value/status/1967580414543016149)  2025-09-15T13:25Z [----] followers, [----] engagements


"Long grumpy post about shorting motivated by quantum computing stocks eg $IONQ which are all basically frauds. Apologies in advance @MartinShkreli. I suspect being right on the facts is not good enough for a short. It's plenty good enough for a long position. There's no way"  
[X Link](https://x.com/Michigan_Value/status/1968729230700683673)  2025-09-18T17:30Z [----] followers, [----] engagements


"market sentiment can cause longs any issues if they can wait it out. A really cheap stock one is long on when it gets cheaper just buy more maybe the company repurchases shares you wind up with an even better outcome over time bc of a temporary bit of market insanity. And it"  
[X Link](https://x.com/Michigan_Value/status/1968729232231547070)  2025-09-18T17:30Z [----] followers, [---] engagements


"doesn't take long to win eg $NXST. Market has put a 5x FCF multiple on it over the past [--] years I've been involved and I'm up 35x. No need for the market to ever "get it" just grow and generate FCF and buyback stock and pay dividends and the market can be as dumb today as it"  
[X Link](https://x.com/Michigan_Value/status/1968729234295107750)  2025-09-18T17:30Z [----] followers, [---] engagements


"tied to any major currency and instead of a commodity it trades on fantasy. Same with bitcoin albeit over a shorter time frame. Silver used to be money & now trades like a commodity. Maybe that eventually happens to gold but [--] years later there's no sign of rationality yet"  
[X Link](https://x.com/Michigan_Value/status/1968729237944234311)  2025-09-18T17:30Z [----] followers, [---] engagements


"For a short one needs to either front run the "voting machine" - typical Haruspex track record suuucks at this - or a catalyst. With quantum computing there's no catalyst imho. It'd be different if there were a deadline like a drug trial or a bankruptcy filing. Rant over"  
[X Link](https://x.com/Michigan_Value/status/1968729239898730874)  2025-09-18T17:30Z [----] followers, [---] engagements


"And people STILL don't get broadcasters. I've been involved at $NXST since [----] and have a 35x on it despite the fact that NXST trades today at 5x FCF just like it did in [----]. Other broadcasters only did ok. Management matters"  
[X Link](https://x.com/Michigan_Value/status/1969052117290590699)  2025-09-19T14:53Z [----] followers, [---] engagements


"Did anyone see the $IONQ CEO on last night's "Pump with Cramer" show I meant to record it and forgot @MartinShkreli"  
[X Link](https://x.com/Michigan_Value/status/1970509159876427884)  2025-09-23T15:22Z [----] followers, [---] engagements


"Cramer with the hard hitting skeptical line of questioning we have come to expect from him in cases of obvious scams like $IONQ amiright @MartinShkreli https://www.youtube.com/watchv=4ejZGiJ4zs4 https://www.youtube.com/watchv=4ejZGiJ4zs4"  
[X Link](https://x.com/Michigan_Value/status/1970538123349127354)  2025-09-23T17:17Z [----] followers, [---] engagements


"@ChrisOlin $HROW is going to $500+ by the end of the decade and then up more from there. People are catching on but slowly"  
[X Link](https://x.com/Michigan_Value/status/1970890990853759232)  2025-09-24T16:40Z [----] followers, [---] engagements


"$HROW shorts have only lost $100M or so since the $22 low in March this year. About 5M shares short now so when the share price hits $100 over the next [--] months that works out to another $500M of losses. Ouch"  
[X Link](https://x.com/Michigan_Value/status/1970974023275380872)  2025-09-24T22:10Z [----] followers, [----] engagements


"@Oddhootcapital My convos w/ $HROW pod shorts: rational types look for "disappointment" on guidance or street; some also have crackpot POV on the company; most think Mark is "promotional" - tbf he is relentlessly optimistic - but can't tell he's also brilliant. Some real dummies in this group"  
[X Link](https://x.com/Michigan_Value/status/1971212168533246161)  2025-09-25T13:56Z [----] followers, [---] engagements


"$HROW now owns Melt. Expect $400 ASP initially $200 ASP for broad use label. I'll leave you to do the arithmetic"  
[X Link](https://x.com/Michigan_Value/status/1971608933220724925)  2025-09-26T16:12Z [----] followers, [----] engagements


"$HROW I should have added that Melt has zero competition. Only alternatives are opioids or needles. Quick question: if someone you care about needs mild/medium pain management would you prefer fentanyl a needle with the same drug as Melt or a [--] second sublingual tablet"  
[X Link](https://x.com/Michigan_Value/status/1971610159228334323)  2025-09-26T16:17Z [----] followers, [---] engagements


"$HROW Before Iheezo patients getting monthly bilateral eye injections reported needing 1-2 days before resuming normal activity. Iheezo takes a few hours. Patients recover "3 to [--] weeks of their life in a given year" - Dr. Raj Patel"  
[X Link](https://x.com/Michigan_Value/status/1971649794578989107)  2025-09-26T18:55Z [----] followers, [---] engagements


"Good lord what a stupid post. $ORCL market cap is $800B debt is $100B"  
[X Link](https://x.com/Michigan_Value/status/1972317213303726218)  2025-09-28T15:07Z [----] followers, [---] engagements


"Of course they are still sell side so they go on to say some silly things later in the note. But the note does get off to a good start"  
[X Link](https://x.com/Michigan_Value/status/1972668381028352267)  2025-09-29T14:22Z [----] followers, [---] engagements


"@genejchan OMG LOLOLOL the thesis is $IONQ is the "valuable" one 🤣🤣🤣🤣🤣🤣"  
[X Link](https://x.com/Michigan_Value/status/1976362744363528588)  2025-10-09T19:02Z [----] followers, [---] engagements


"@TylerRe98565311 $IONQ are literally con men who are lying to you. Glad you had a nice outcome. No position btw never had one. Just. be careful of snake oil"  
[X Link](https://x.com/Michigan_Value/status/1978054593876471952)  2025-10-14T11:05Z [----] followers, [---] engagements


"@DrEliDavid Blerg. They sell stock at absurd prices and raise tons of cash. How does $IONQ drop 99% when they have 7.5% of their market cap in cash The business is a fraud but it won't drop 99%. See $GME. Sold shares into bubble now has $9.2B cash&bitcoin market cap $10.3B"  
[X Link](https://x.com/Michigan_Value/status/1978098239044813196)  2025-10-14T13:59Z [----] followers, [---] engagements


"Quantum frauds will NOT drop 99% from here bc they sell stock into the bubble. How does $IONQ drop 99% with 7.5% market cap in cash Consider $GME. Sold shares into bubble now $9.2B cash & bitcoin market cap $10.3B. See what I mean"  
[X Link](https://x.com/Michigan_Value/status/1978098945101332938)  2025-10-14T14:01Z [----] followers, [---] engagements


"@iewney Thoughts & prayers. Fortunately it can't go to zero despite being a worthless company bc the stock they dumped into the bubble is now cash on the b/s. Like $GME which now trades at cash. Mgmt dumped $1B into the bubble at the expense of ya know whoever was buying the bubble"  
[X Link](https://x.com/Michigan_Value/status/1978907011329716310)  2025-10-16T19:32Z [----] followers, [---] engagements


"@genejchan $IONQ computers literally cannot add two [--] digit numbers together today. The thing you think happened did not happen. And it has been debunked. You're welcome"  
[X Link](https://x.com/Michigan_Value/status/1978922870718738821)  2025-10-16T20:35Z [----] followers, [---] engagements


"Meanwhile Xiidra sucks and BLCO is lowering guidance there. BC Xiidra is not an SA drug. And we all knew this already right There's clinical trial data. Xiidra data sucks. Restasis data sucks same with Cequa and all the other DED drug data for everything except the SAs"  
[X Link](https://x.com/Michigan_Value/status/1818670889568702912)  2024-07-31T15:31Z [----] followers, [---] engagements


"And the clinical trial data that doesn't suck Well there are two and they are both SA drugs both developed by Novaliq and licensed in the US. Miebo to $BCLO and Vevye to $HROW. The data are not hard to read. I am a scientist but you don't have to be one to read these"  
[X Link](https://x.com/Michigan_Value/status/1818670890869051541)  2024-07-31T15:31Z [----] followers, [---] engagements


"$BCLO and $HROW clinical trial data. Adverse events profile: Xiidra 51.7% Miebo 11.4% Vevye 10.2%. Efficacy data also superior for the SA drugs Miebo & Vevye. How obvious is it that drugs that work faster and better and don't hurt to use will win market share"  
[X Link](https://x.com/Michigan_Value/status/1818676437143924763)  2024-07-31T15:53Z [----] followers, [---] engagements


"$HROW 10yr revenue CAGR 35%. Up each yr except pandemic then down a smidge. It's like watching $BRKB $BRKA Warren Buffett "compound"😆during his old partnership days"  
[X Link](https://x.com/Michigan_Value/status/1863563762436878833)  2024-12-02T12:39Z [----] followers, [----] engagements


"$ETON article. It's free. You're welcome ;-) https://seekingalpha.com/article/4788714-eton-pharmaceuticals-set-to-dominate-orphan-drug-niche https://seekingalpha.com/article/4788714-eton-pharmaceuticals-set-to-dominate-orphan-drug-niche"  
[X Link](https://x.com/Michigan_Value/status/1925164329072017570)  2025-05-21T12:18Z [----] followers, [---] engagements


"I first bought $ETON last year at $3.50 now $19. And the amazing thing is that I own more now than I did then at a much lower price. Execution is amazing management just killing it. $100 is coming maybe more"  
[X Link](https://x.com/Michigan_Value/status/1925180058194297121)  2025-05-21T13:21Z [----] followers, [----] engagements


"$ETON is about to dominate the Orphan Drug niche the way $HROW dominates the compound pharmacy niche"  
[X Link](https://x.com/Michigan_Value/status/1925695549807669255)  2025-05-22T23:29Z [----] followers, [----] engagements


"@TOWiU2 @WallStPirate $BLCO began a huge DTC marketing campaign with the start of [----] possibly you have seen their TV commercials That's what you are seeing on the graph. Obviously it isn't cheap so likely Miebo is losing money for now"  
[X Link](https://x.com/Michigan_Value/status/1929530374259937762)  2025-06-02T13:27Z [----] followers, [---] engagements


"Shameless plug: new article out on $HROW and $ETON on my pay service"  
[X Link](https://x.com/Michigan_Value/status/1937568652334694491)  2025-06-24T17:48Z [----] followers, [----] engagements


"@TR_LA2 $HROW can't compete on DTC ad spending with $BLCO just like they can't afford [---] sales reps (yet). Miebo is killing it but BLCO is likely burning a ton of cash on it so far. HROW has to launch efficiently and hope that having the best drug and the best access will be enough"  
[X Link](https://x.com/Michigan_Value/status/1943411343039631759)  2025-07-10T20:45Z [----] followers, [---] engagements


"Xiidra [----] $487M [----] $390M [----] $364M Q2 [----] down 8% YOY. Interest on $1.75B up front $150M/yr no idea if they triggered milestones. What's the EBITDA margin on Xiidra 50% maybe Rapidly approaching where EBITDA can't pay the interest even on the up front"  
[X Link](https://x.com/Michigan_Value/status/1952045242242203832)  2025-08-03T16:33Z [----] followers, [---] engagements


"$HROW $ALC DED drug Tyrvaya: poor trial data but why read clinical trials when salespeople are honest & attractive & really want to hear your opinion doctor and have you been working out Here have a muffin. Poor results matter eventually e.g. Xiidra. Vevye has amazing data"  
[X Link](https://x.com/Michigan_Value/status/1952715390464704964)  2025-08-05T12:56Z [----] followers, [----] engagements


"@AktienAkademie You mean how do you do the arithmetic $HROW Q2 net debt $169M Q2 EBITDA $17M & growing fast & Q4 seasonally strong (Q1 seasonally weak). Sub 2x trailing results from e.g. $65M 2H EBITDA and at least $10M FCF or $60M 2H EBITDA and $20M FCF etc. Does that help"  
[X Link](https://x.com/Michigan_Value/status/1956719926154260930)  2025-08-16T14:09Z [----] followers, [---] engagements


"@themateuszcaban @ChrisOlin @MitchMartan98 wisdom"  
[X Link](https://x.com/Michigan_Value/status/1971173361662455892)  2025-09-25T11:22Z [----] followers, [---] engagements


"Some may see this & think: hmm added biosimilars and didn't raise guidance. is something wrong Understandable but no. Investors asked $HROW to underpromise/overdeliver & starting with [----] guidance - which they beat despite some issues - they have been. That's what this is"  
[X Link](https://x.com/Michigan_Value/status/1973798531573117270)  2025-10-02T17:13Z [----] followers, [----] engagements


"@RevShark Started [--] yrs ago. Investors (including me) convinced them in late '23 '24 guide was lowball. Also took advice re/ "at least" guidance. '24 "at least" $180M '25 "at least" $280M. $HROW "gets it" now. This will become obvious to everyone might take a few more quarters though"  
[X Link](https://x.com/Michigan_Value/status/1974628494794776640)  2025-10-05T00:11Z [----] followers, [---] engagements


"@commonsenseplay Dude it's not going to go bankrupt. $RGTI has a $13B market cap & issues stock as needed; just did $350M in Q2. Now have $575M cash no debt. [----] burn=$60M. Don't make bears look stupid ok That's not helpful"  
[X Link](https://x.com/Michigan_Value/status/1974883075114066117)  2025-10-05T17:03Z [----] followers, [---] engagements


"Quantum computing=hype & some frauds (cough cough $IONQ $QBTS) but NOT about to go bankrupt. Example: $RGTI $13B market cap issue stock as needed; raised $350M in Q2 '25. Now $575M cash no debt. [----] burn=$60M. Not going bankrupt ok RGTI also not a fraud imho. Seem honest"  
[X Link](https://x.com/Michigan_Value/status/1974887506161410528)  2025-10-05T17:20Z [----] followers, [----] engagements


"$HROW PR today = IR problems = fixed. Immy CEO Saharek out days after presenting at investor day. PR doesn't mention him but new Head of Quality Bridseida Cruz is "known for driving FDA remediation". Market jumps to conclusion: FDA problems https://www.harrow.com/news-releases/news-release-details/imprimisrx-announces-leadership-changes https://www.harrow.com/news-releases/news-release-details/imprimisrx-announces-leadership-changes"  
[X Link](https://x.com/Michigan_Value/status/1975334920655614012)  2025-10-06T22:58Z [----] followers, [----] engagements


"Reality: Immy grew like crazy when Mark was running it and now that Mark needs to pay attention to branded pharma he needs someone to handle Immy. Saharek has maybe always been in over his head. New Immy CEO Frank Mullery ran a $1B division at Mylan; he can handle growing Immy"  
[X Link](https://x.com/Michigan_Value/status/1975334922786345372)  2025-10-06T22:58Z [----] followers, [---] engagements


"Bridseida Cruz has been with $HROW since July. Not a new hire. Resume is great. And she was not hired bc of FDA issues. How do we know this https://www.linkedin.com/in/bridseida-cruz-844492160/ https://www.linkedin.com/in/bridseida-cruz-844492160/"  
[X Link](https://x.com/Michigan_Value/status/1975334924426326219)  2025-10-06T22:58Z [----] followers, [----] engagements


"Because the FDA's website shows nothing; and because an 8k from 9/12/25 says no FDA problems https://www.sec.gov/Archives/edgar/data/1360214/000149315225013268/form8-k.htm https://www.sec.gov/Archives/edgar/data/1360214/000149315225013268/form8-k.htm"  
[X Link](https://x.com/Michigan_Value/status/1975334926435168447)  2025-10-06T22:58Z [----] followers, [----] engagements


"My take: $HROW didn't expect a reaction to the PR. Just another day at the office. But after generating good will with that great investor day buy side added $HROW has their boss is asking: did we buy a stock with FDA trouble They didn't but the confusion is understandable"  
[X Link](https://x.com/Michigan_Value/status/1975334929157460053)  2025-10-06T22:58Z [----] followers, [----] engagements


"@mvcinvesting Yeah some crazy conspiracy theories out there. $HROW IR has been on the phone all day today quashing this one"  
[X Link](https://x.com/Michigan_Value/status/1976334407075242089)  2025-10-09T17:10Z [----] followers, [---] engagements


"@John_Porter10 ugh why do people keep saying dumb stuff like this They will NOT run out of money because they issued shares into the bubble and will again. $575M cash burn rate is $60M/yr. Not running out"  
[X Link](https://x.com/Michigan_Value/status/1978424839233753347)  2025-10-15T11:36Z [----] followers, [---] engagements


"$IONQ mgmt dumped $1B of stock into the bubble. $RGTI CEO owns no shares. Sold them all. Can't zero though. Companies sold shares into the bubble=cash on the b/s now. $GME did that too & trades at cash now. These will all trade at cash some day. Management knows that"  
[X Link](https://x.com/Michigan_Value/status/1978908622005383659)  2025-10-16T19:39Z [----] followers, [----] engagements


"$IONQ $QBTS $RGTI shorting quantum frauds is fraught with peril but one can also make some nice coin. Tempted to say "so long and thanks for all the fish" at this point"  
[X Link](https://x.com/Michigan_Value/status/1980639684113191115)  2025-10-21T14:17Z [----] followers, [---] engagements


"If the previous comment makes sense to you great. If it doesn't and if you think you know what's up with quantum computing that's a major red flag. That doesn't mean quantum computers won't be useful someday. But until one wraps their head around how useful and when"  
[X Link](https://x.com/Michigan_Value/status/1980639692115808645)  2025-10-21T14:17Z [----] followers, [--] engagements


"prolly $GME all over again. Or $BYND or weed stocks etc. And can you tell which one's are frauds $RGTI overpriced but = fraud. CEO owns zero shares is careful about what he says no risk of prison imho. Some other CEO's seem more open to the idea 🤣jk"  
[X Link](https://x.com/Michigan_Value/status/1980639693814526278)  2025-10-21T14:17Z [----] followers, [---] engagements


"Prediction: qc companies & management dump shares bigly into bubble. Honest CEO's e.g. $RGTI = pump discuss goals and achievements. Compare to $IONQ CEO public comments. Eventually all trade at cash plus a bit. Value cash raised selling into the bubble. Just like $GME today"  
[X Link](https://x.com/Michigan_Value/status/1980639695550988632)  2025-10-21T14:17Z [----] followers, [---] engagements


"There's a meme etf $MEME Top [--] holdings include quantum frauds $IONQ $QUBT $QBTS $RGTI. Incredible real time study of bubble psychology. Some true believers some traders trying to front run the FOMO some con men & some trying to time the inevitable crash as shorts"  
[X Link](https://x.com/Michigan_Value/status/1980765933850292251)  2025-10-21T22:39Z [----] followers, [----] engagements


"@themateuszcaban @SPAC_Infleqtion I don't think I understand the question I think I've made my POV pretty clear on quantum computing stocks. What's the confusion"  
[X Link](https://x.com/Michigan_Value/status/1980949319252664605)  2025-10-22T10:48Z [----] followers, [--] engagements


"@MartinShkreli Don't they have $10/share of cash I can see $IONQ going to $10 but how can it go to zero"  
[X Link](https://x.com/Michigan_Value/status/1980951407131017344)  2025-10-22T10:56Z [----] followers, [---] engagements


"@themateuszcaban @SPAC_Infleqtion $CCCX prolly trades at cash from selling shares into bubble once bubble ends. But it's a real company & 1/4 market cap of frauds=long CCCX/short $IONQ $QBTS $RGTI $QUBT might make sense. Citron's idea. Not crazy. Maybe better to just short the other [--] though"  
[X Link](https://x.com/Michigan_Value/status/1981050590034530341)  2025-10-22T17:30Z [----] followers, [---] engagements


"Just a quick reminder that all the quantum frauds will trade at a bit more than the cash on their balance sheets at some point. They smartly dumped tons of shares into the bubble so no risk of a zero. $IONQ has $10/share of cash for example. Can't hit zero for this reason"  
[X Link](https://x.com/Michigan_Value/status/1981074870227062831)  2025-10-22T19:07Z [----] followers, [---] engagements


"$HROW Tegus interview with a DED specialist: "Restasis doesn't work at all but insurance companies want us to try it first. Sometimes we have to try it but it really doesn't work. Xiidra works differently than all the cyclosporines"  
[X Link](https://x.com/Michigan_Value/status/1990164663691317426)  2025-11-16T21:06Z [----] followers, [----] engagements


"Quantum frauds are doing what they should do: settle at about cash per share over time. It's meme vs reality. Look at $GME to see the future of $IONQ $RGTI $QUBT $QBTS I'm a physicist. What the longs in this space think is true about the science = what is really true"  
[X Link](https://x.com/Michigan_Value/status/1991914978014826718)  2025-11-21T17:01Z [----] followers, [---] engagements


"@genejchan Do you actually believe in this stuff or is it just a con Naive but innocent or clever but nefarious In case it's the former the proper read is from the $RGTI CEO. Science project owns zero shares. You're welcome. If it's the latter then you already know ;-)"  
[X Link](https://x.com/Michigan_Value/status/1991918004465189059)  2025-11-21T17:13Z [----] followers, [---] engagements


"New $HROW article out today on my pay service: https://seekingalpha.com/mp/1414-concentrated-value-with-mvi/articles/6227577-hrow-end-of-the-weirdos https://seekingalpha.com/mp/1414-concentrated-value-with-mvi/articles/6227577-hrow-end-of-the-weirdos"  
[X Link](https://x.com/Michigan_Value/status/1992076484786471240)  2025-11-22T03:43Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@Michigan_Value Avatar @Michigan_Value Michigan Value Investor

Michigan Value Investor posts on X about $hrow, $ionq, bloomberg, $rgti the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance stocks technology brands cryptocurrencies countries social networks exchanges automotive brands

Social topic influence $hrow #2, $ionq, bloomberg, $rgti, money, cvs #205, insurance, $1b, in the, business

Top assets mentioned IonQ, Inc. (IONQ) Rigetti Computing, Inc. Common Stock (RGTI) CVS Health Corp (CVS) D-Wave Quantum Inc. (QBTS) Quantum Computing Inc. (QUBT) GameStop, Corp. (GME) Bausch & Lomb Corp (BLCO) Nexstar Media Group, Inc. Class A Common Stock (NXST) Atkore Inc. (ATKR) Amazon.com, Inc. (AMZN) NVIDIA Corp. (NVDA) Bitcoin (BTC) MemeCoin (MEME) SPDR S&P [---] ETF Trust (SPY) Joby Aviation, Inc. (JOBY) Berkshire Hathaway Inc Class B (BRK.B) Alcon Inc. Ordinary Shares (ALC)

Top Social Posts

Top posts by engagements in the last [--] hours

"Midwits think $ATKR doesn't have a moat bc it sells mostly commodity products. $COST sells mostly commodity products. Does $COST have a moat"
X Link 2024-07-07T15:16Z [---] followers, [---] engagements

"@European_DGI Do you know what the buyback yield is after deducting share based comp"
X Link 2024-07-21T14:17Z [---] followers, [---] engagements

"Something like 5% of political ad spending winds up as pre-tax FCF at $NXST. Who thinks political ad spending will do well this year And who thinks political ad spending is going to grow - every other year ofc - from here"
X Link 2024-07-22T19:56Z [---] followers, [---] engagements

"Does anyone know how far along $CRWD is in their plan to change their ticker symbol to $OOPS"
X Link 2024-07-23T16:24Z [---] followers, [---] engagements

"Is it obvious that $HROW would be cheap even if Vevye were their only product and they were losing money as they ramp it up That would be obvious right"
X Link 2024-07-31T19:42Z [---] followers, [---] engagements

"@John_Hempton I mean yeah. I'm up 100% this year. I get why someone would pay me for investing advice. Why would anyone pay Cathy"
X Link 2024-08-09T14:20Z [---] followers, [--] engagements

"This thread connects to $HROW eventually though it starts with $AMZN. People at funds who have done well are often unaware that they've been lucky and that can lead to mistakes. I'll give an example using myself"
X Link 2024-08-11T15:04Z [---] followers, [---] engagements

"If I were your PM - and I've had that job - this is the conversation we would be having. Much like the conversation I had with myself about $AMZN. It made me a better investor to be so ruthless with myself btw. You're welcome"
X Link 2024-08-11T15:04Z [---] followers, [---] engagements

"Just saw the most recent IQVIA data for $HROW's Vevye. Up and to the right is considered good right"
X Link 2024-08-13T14:24Z [---] followers, [----] engagements

"OMG. I will get this right eventually. Vevye about to be fifth. Top [--] are restasis miebo generic cyclo and Xiidra"
X Link 2024-08-13T21:57Z [---] followers, [---] engagements

"$HROW recent two week Vevye average is 3500/wk or about 15k/month. Pro-forma for $200 ASP fully insured they are running $3M/month right now. At this pace $75M Vevye in [----]. That's where we are rn with no Medicare coverage and [--] reps"
X Link 2024-08-26T19:28Z [---] followers, [----] engagements

"@bsg_cap How about: Management well known to be mistake prone; One never knows for sure about clinical trials. After the run up share price was cheap only if the trial went well and only if management didn't destroy value. FWIW these are the reasons I passed on @MOB.ST"
X Link 2024-09-14T22:21Z [---] followers, [---] engagements

"@PedroLamento Craig at $CPH.TO is actually pretty smart as far as I can tell. He will almost certainly make a rational decision here imho. Also Cipher is up 3x over the last year as you are well aware. I think Craig's PA is juuuust fine ;-)"
X Link 2024-09-16T15:41Z [---] followers, [----] engagements

"Have people heard the argument that if the Fed lowers rates [--] bps it will spook the market bc people will think the Fed "knows something" Does anyone actually believe the Fed knows anything"
X Link 2024-09-16T16:24Z [---] followers, [---] engagements

"When everything is fine the Fed is supposed to set rates at neutral. Neutral is maybe 3-3.5%. The Fed thinks the economy is fine and inflation is in check so they are moving to neutral. Why is this confusing"
X Link 2024-09-19T12:24Z [---] followers, [---] engagements

"@Russell_A1221 The Fed has done some odd things. But this move to normalize seems anything but odd right"
X Link 2024-09-19T12:27Z [---] followers, [--] engagements

"@LukeWolgram nah dead wrong. find the best stock ideas you can and they are what they are. You can't specifically pick ahead of time to "find doubles" vs finding [--] baggers. And btw if one does find a few ten bagger potential stocks often some of them don't work out 10x but wind up 2x"
X Link 2024-09-21T14:38Z [---] followers, [---] engagements

"$HROW Vevye and $MOB.TO $CPH.TO MOB-015 are similar. Clinical trial data great active ingredient well known efficacy better delivery vehicle. Most patients don't treat disease bc legacy drugs suck. Market share but also they will grow the market"
X Link 2024-09-23T15:15Z [---] followers, [----] engagements

"$MOB.ST comrades: does everyone understand why a MOB-15 study with an extended observation period after treatment would fail There's a reason it would. Here's the thing. A nail that has a myco cure winds up with fungus again 50% of the time. Did you guys know that"
X Link 2024-09-23T18:41Z [---] followers, [----] engagements

"And whether this is a relapse or reinfection who knows. Could be the fungus is still there but suppressed to the point the test can't detect it. And it could be that people don't change their sox and the fungus comes back. Either way a 76% myco cure = 38% for real cure"
X Link 2024-09-23T18:41Z [---] followers, [---] engagements

"MOB was hoping that a lower dosage 1x/wk of MOB-015 would be enough to finish treatment and prevent recurrence after initial [--] weeks at 1x/day. But it isn't. Whiteness maybe related to nail porosity And w/o porosity terbinafine sits on the outside of the nail useless"
X Link 2024-09-23T18:41Z [---] followers, [---] engagements

"Best move imho Just sell it as is. Tell people it gets a 76% myco cure and let them decide if they want it. I like their chances. If I had nagelsvamp - my new favorite word - I would def use it. Import it from Sweden if need be. Where btw MOB-015 is killing it"
X Link 2024-09-23T18:41Z [---] followers, [---] engagements

"And then from there. maybe come up with a study to extend the patent. That would be valuable if they can think of a way. But first sell it. Gotta sell it and get some cash flow"
X Link 2024-09-23T18:41Z [---] followers, [---] engagements

"People really don't understand just how big this is going to be. So many models I see are just delusional. 3e has a J code demand is through the roof price is $944 before discounting. 90k units produced already some of which were used in testing. They will sell all units"
X Link 2024-09-24T17:15Z [---] followers, [---] engagements

"@PythiaR Which is a pass on the litmus test owning it or failing to own it"
X Link 2024-09-24T17:17Z [---] followers, [---] engagements

"The first was $NXST in [----] a nice 30x ride since then. Guys it's amazing what even one of these does for performance a "Black Swan" that works in one's favor. They can be found. I keep preaching but like some Bizzarro Cassandra I convince almost no one"
X Link 2024-09-24T19:28Z [---] followers, [---] engagements

"@Russell_A1221 That's it Hansen natural. Looked at it and passed. so dumb. Also I talked my friend out of Apple in [----]. So many mistakes. Hard to imagine how I could have been so dumb and still wind up doing so well"
X Link 2024-09-24T19:47Z [---] followers, [---] engagements

"$MOB.ST's whitening effect is water in the nail. Likely aids in transporting terbinafine from the nail surface to under the nail. This may be why the vehicle works. No need to overthink where water comes from. It's in the air human skin sweat and people get their toes wet"
X Link 2024-09-26T14:51Z [---] followers, [----] engagements

"@SebKrog I sure as heck hope he is strategic about it since I am long $CPH.TO. Either way I think he might be. It seems clear MOB-15 will sell well to me anywhere but Japan where it's likely DOA. I think Craig knows that and is smart and there's no reason not to press the advantage"
X Link 2024-09-26T15:59Z [---] followers, [---] engagements

"@illyquid @SebKrog Jublia is deeply entrenched and regulators are fixated on "complete cure" rates. Prolly can't convince them"
X Link 2024-09-26T16:05Z [---] followers, [---] engagements

"@PythiaR It's a fair point. It's also fair to point out that MOB raised a lot of cash when the share price was higher. That cash on the balance sheet may be the main reason MOB shareholders aren't down LTM Agree the story is far from over though"
X Link 2024-09-29T12:04Z [---] followers, [---] engagements

"And that's it"
X Link 2024-09-29T13:52Z [---] followers, [----] engagements

"@ReganCoda That's unkind. Also those stocks have done alright. TTM $CPH.TO up 240% $MOB.ST up 50%. Big drop recently I'll give you that"
X Link 2024-09-29T16:17Z [---] followers, [---] engagements

"@PythiaR well sure. I answered the question but I haven't spelled out the details for you. The full analysis is more thoughtful but I will not be posting it on twitter. As an aside you have my all time favorite handle. Well done"
X Link 2024-09-29T19:14Z [---] followers, [---] engagements

"@ReplyGuy_Cap @PedroLamento @PythiaR Oh I want to be VERY clear that the game is not over. M15 will sell well imho and I hope to profit from it. Fortunately for me I avoided the recent challenges. I think people might be interested in the reasoning hence the post. But where things go from here remains to be seen"
X Link 2024-09-30T12:48Z [---] followers, [---] engagements

"Reposting this from 9/23 to highlight my POV on m15. You guys all hopefully know how bullish I am on Vevye at $HROW so hopefully this clears things up for anyone confused on what I have said in the past about m15"
X Link 2024-09-30T15:42Z [---] followers, [---] engagements

"@ChrisOlin @PedroLamento Anna is imperfectly aligned with shareholder of $MOB.ST. That is true. I would expect some effort will be made to keep management's salaries safe. Clearly enough cash on the balance sheet rn to pay management for many years to come however. A raise is not needed just for that"
X Link 2024-09-30T19:31Z [---] followers, [---] engagements

"@PedroLamento @ChrisOlin Honestly that's just awesome. Love the passion It would be better to have an easy path to full insurance coverage but the other side is that the product works so well. FWIW my guess is m15 gets monetized in the US. but we shall see"
X Link 2024-10-04T12:02Z [---] followers, [---] engagements

"Compounding is a different. Customers tell $HROW what they are looking for. For branded drugs a company has a drug and tries to sell it. But in compounding the customers tell you what they are looking for. For the right CEO this insight could prove valuable. Moat"
X Link 2024-10-06T13:35Z [---] followers, [---] engagements

"And I met CEO Baum. Very smart and totally obsessed with $HROW. People like Mark can be insanely driven to build the company that they love. I've known people like this. They literally truly love the company they build some of them. Can you think of any founders like that"
X Link 2024-10-06T13:35Z [---] followers, [---] engagements

"@TrentBlair19 Well obviously would have been Mark Baum at $HROW but not sure it's still a microcap now that it's up so much"
X Link 2024-10-08T17:43Z [---] followers, [---] engagements

"@Divergent7651 It says something positive about the moat around the business. Most management can't afford to give away critical pricing information to their competition. $AZO doesn't have to care about competition much so this is fine. For a different business with less moat not so much"
X Link 2024-10-09T12:05Z [---] followers, [---] engagements

"True lollapalooza potential in small cap pharma. Not just $HROW $CPH.TO. Well managed companies can be bought by investors at low prices AND management can acquire products like Natroba Vevye and 3e for a song = lollapalooza. I'm up 5x YTD24. Will be way up in [----] too"
X Link 2024-10-10T14:02Z [---] followers, [----] engagements

"Crappy companies like $BLCO with poor management make bad acquisitions and pass on the good stuff. One has to be able to tell the difference. But for an investor that can It's a frickin' golden age"
X Link 2024-10-10T14:02Z [---] followers, [---] engagements

"@PedroLamento Yup nailed it imho. 1/wk maintenance either 1) doesn't whiten & doesn't make the nail porous to terb; or 2) does both. This makes aesthetic cure labeling tricky even tho the drug excels at killing fungus. No easy trial design but m15 works & people want it. That matters"
X Link 2024-10-12T11:38Z [---] followers, [----] engagements

"$HROW isn't always rationally traded @Montrea92285044"
X Link 2024-10-16T19:38Z [---] followers, [---] engagements

"@ChrisOlin This is so funny"
X Link 2024-10-17T18:44Z [---] followers, [---] engagements

"@PythiaR ok thanks"
X Link 2024-10-18T12:13Z [---] followers, [---] engagements

"@ttril22 well these sorts of things come along infrequently. The last was [--] years ago when I bought $NXST for $6 and change [--] bagger since. Then $HROW. It might be another [--] years before I find another one"
X Link 2024-10-18T16:26Z [---] followers, [---] engagements

"@PedroLamento Sheesh you and I must have very different definitions of what a shitco is"
X Link 2024-10-22T13:45Z [---] followers, [---] engagements

"@PedroLamento $CPH.TO is a well managed non-cyclical company with a moat positive FCF modest debt and excellent growth prospects. That's the opposite of a shitco"
X Link 2024-10-22T13:49Z [---] followers, [---] engagements

"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfmAI=Triamcinolone%20Acetonide%20Injection&st=c https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfmAI=Triamcinolone%20Acetonide%20Injection&st=c"
X Link 2024-10-24T17:34Z [----] followers, [---] engagements

"@marketplunger1 Sure. Best guess you are only considering $PTON bc Einhorn pump. He did some solid work a long time ago but has kinda sucked for a while. You'd be paying up compared to recent prices. You may not know much about it. you did call it "a flyer". Always a red flag. Does that help"
X Link 2024-10-25T14:10Z [----] followers, [---] engagements

"$HROW new IQVIA data shows Iheezo running 17k units/month or about $18.5M per quarter of net revenue to HROW @$366 (not WAC). Retina just now taking off. Iheezo [----] $100M+ revenue slam dunk at this point"
X Link 2024-10-29T17:01Z [----] followers, [----] engagements

"My $MOB.ST journey: Normally a Swedish microcap would be off my radar but Moberg was discovered by a colorful group on Twitter. And there was some good work that they did and they got some things really really right. They were right about m15 that's for sure"
X Link 2024-11-18T16:09Z [---] followers, [----] engagements

"@FelixSchreibe13 @gasparespontin1 Wait you don't want to discuss how I'm up 70% on Moberg in a couple months And 5x YTD overall I guess I'm the idiot you're the genius. Point taken and thanks for putting me in my place 😆"
X Link 2024-11-18T16:25Z [---] followers, [---] engagements

"@arbiter_jack Think through what you just said and then answer your own question"
X Link 2024-11-18T19:24Z [---] followers, [---] engagements

"@Michael15107053 My grandma used to say "If wishes were horses beggars would ride". Feel free to wish but $HROW is likely the buyer"
X Link 2024-11-18T19:25Z [---] followers, [---] engagements

"$MOB.ST [----] m15 EU launch probable more than $0.50 pre-tax FCF/sh coming in the EU alone. Already in Sweden huge success right away. No debt $0.60/share of cash $1/sh milestone payments coming. Stock at $1.50. Likely more launches in US and RoW. Too cheap"
X Link 2024-11-19T12:39Z [---] followers, [----] engagements

"@WallStPirate The milestone is additional payments from Bayer to Moberg if certain objectives are met. Details are not known but milestone payments are common. Only Sweden launched in [----] half the EU launches in Q1 [----] the rest hopefully soon after"
X Link 2024-11-19T13:03Z [---] followers, [---] engagements

"@kneesovertoesg I will never dunk but my knees are in great shape now. Thanks"
X Link 2024-11-19T19:25Z [---] followers, [---] engagements

"@winsteadscap Weird daydream. Imagining oneself in the major leagues. and hitting a single with no one on. The crowd politely applauds"
X Link 2024-11-19T19:36Z [---] followers, [----] engagements

"$ATKR numbers just not good at all but actually about where I would have put them a few years ago if not for them telling us to expect so much better. I had such confidence in mgmt guidance that I replaced my own estimate with theirs. I really blew it there. My bad"
X Link 2024-11-21T13:02Z [---] followers, [----] engagements

"$BRKB People don't realize just how good Warren Buffett was. They think they do but they don't"
X Link 2024-11-26T15:40Z [---] followers, [---] engagements

"Um no one thinks there's any chance of anything other than a failed US phase [--] trial for $MOB.ST right The company was pretty clear about this. I would think it was already in the market but maybe some people don't know"
X Link 2024-12-03T20:16Z [---] followers, [----] engagements

"$MOB.ST m15 US phase3 trial will fail to meet its primary endpoint according to Moberg. Yet some people think it trades down when the trial reads out. Is this likely I am fascinated by the prospect & stand ready to profit. But is anyone really that dumb"
X Link 2024-12-04T13:05Z [---] followers, [----] engagements

"$HROW how can anyone look at this and not be impressed Other than by being dumb I mean"
X Link 2024-12-06T20:42Z [---] followers, [----] engagements

"$MOB.ST was all set to launch OTC in the US. Had all their ducks in a row. Just needed that US clinical trial to be "good enough" for FDA approval. Whoever said OTC in the US couldn't be done was flat out wrong"
X Link 2024-12-12T17:26Z [---] followers, [----] engagements

"The logic for this trial imho: whitening begins in earnest at [--] wks. [--] wks daily and then weekly = overkill if linear response. Extending past [--] wks = more whitening but more myco. Would [--] or [--] be better apriori No way to know"
X Link 2024-12-12T19:17Z [---] followers, [---] engagements

"So they tried something reasonable and tested it. Experiment is how science works. If it worked they would have extended the patent and launched Rx in the US. If it worked less well they could launch OTC in the US. Not crazy but didn't work"
X Link 2024-12-12T19:17Z [---] followers, [---] engagements

"And for those who think they know a better trial well if one is willing to settle for OTC in the US then yes. Just redo the Europe trial. For a US Rx launch you need something clever like what they did but which works"
X Link 2024-12-12T19:17Z [---] followers, [---] engagements

"@miamimike999 I don't think I am in a position to say for sure whether the trial was optimal given what was known. As far as I can tell it was a reasonable trial design if the goal was to launch Rx in the US and extend the patent"
X Link 2024-12-12T21:30Z [---] followers, [---] engagements

"@NerdcapK yes. they need another phase [--] trial to satisfy the FDA. And that costs time and money and then the launch itself would require management attention that they have decided to devote to the EU. It might happen but it's not simple imho"
X Link 2024-12-12T21:32Z [---] followers, [--] engagements

"$HROW blog post. It's free. https://seekingalpha.com/instablog/213542-michigan-value-investor/6098014-graph-of-hrows-40-percent-revenue-cagr https://seekingalpha.com/instablog/213542-michigan-value-investor/6098014-graph-of-hrows-40-percent-revenue-cagr"
X Link 2024-12-14T14:22Z [---] followers, [----] engagements

"@bioturds That's what people said about $AMZN for all those years ;-)"
X Link 2024-12-18T12:57Z [---] followers, [--] engagements

"Given that trials fail all the time who would ever develop a drug if it's a loser even when the results are great. And yet that's how $MOB.ST trades. As if the drug itself is of little value. They have $0.65/share in cash and trade for $1"
X Link 2024-12-18T15:04Z [---] followers, [---] engagements

"$HROW blog post. It's free. https://seekingalpha.com/instablog/213542-michigan-value-investor/6100060-hrows-stock-price-is-volatile-business-isnt https://seekingalpha.com/instablog/213542-michigan-value-investor/6100060-hrows-stock-price-is-volatile-business-isnt"
X Link 2024-12-19T18:45Z [---] followers, [----] engagements

"@JoeBotticelli Imagine thinking Moberg sells products at a loss. I don't know what to say to this exactly. how about "capitalism isn't like that" Some people think it should be but no it's not"
X Link 2024-12-19T18:48Z [---] followers, [---] engagements

"$HROW's Iheezo data. No need to over react to one week and note that end of Q sales always tick way up. On track for $100M Iheezo in [----]. Will Iheezo exceed Vevye in [----] Tough call. Vevye also tracking to $100M in [----]. Either may inflect"
X Link 2025-01-03T14:56Z [---] followers, [----] engagements

"$HROW any heroes out there care to share the latest IQVIA data 🙏"
X Link 2025-02-06T16:14Z [---] followers, [----] engagements

"Some really big news coming at $HROW. Can hardly believe what I am hearing"
X Link 2025-02-24T16:20Z [---] followers, [----] engagements

"$HROW guiding [----] EBITDA way up as a % of revenue and 40% revenue growth. In [----] EBITDA was negative. Is this trend good"
X Link 2025-04-24T17:03Z [---] followers, [----] engagements

"$HROW $ETON imagine actually understanding the businesses comparing to the price and making investment decisions on that basis and making tons of $. Sound impossible It's actually not even hard"
X Link 2025-05-21T17:17Z [----] followers, [----] engagements

"$ALC's Tryptyr or $HROW's Vevye Tryptyr treats dry eye disease - causing pain on installation in 50% of patients - by helping tear formation. So the drug that causes pain also causes tears. Anyone else see a connection Vevye works better and doesn't hurt so"
X Link 2025-06-05T12:51Z [----] followers, [----] engagements

"will run higher if revenue ramps from here. But one needs to understand why there was extra spending in [----] compared to [----] in order to do that which ofc I do and it's not hard to understand. But that aside just looking at the data itself these are clearly up and to the"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"right over the last [--] years. There's zero doubt about that. Small cap pharma companies always burn cash during the ramp of new drug launches. HROW is able to be FCF neutral during this phase - very unusual - because the legacy business is generating enough cash to offset these"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"losses. The way it usually works in small cap pharma is that the new drug burns cash early on and then if it's successful - this is the big if - but IF it ramps THEN it becomes a FCF machine. My only claim about HROW on this front is that it's the same for them as for every"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"other new drug launch. Iheezo and Triesence and Vevye all burn cash for a while but then if they ramp they will generate cash. They launched Iheezo in [----] and then Vevye and Triesence in [----]. This is very early in the process and even without interest expense this should be"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"a negative FCF time for them. But the rest of the business generates cash pays the interest and offsets the new launch cash burn. HROW also spends a lot less when launching drugs than other companies. They can get away with this - if they can let's see if they really do ramp as"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"much as I hope they do - because of the existing distribution from the legacy company. That's the part that makes HROW different. It's that they built a distribution company using the legacy compounding business. The new launches still burn cash until/unless they ramp just not"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"as much as a regular small cap pharma. This ability to launch efficiently is also why they are able to buy drugs so cheaply and pay the sellers with royalties. HROW can launch Iheezo and Vevye and now Byqlovi and soon Melt with much higher odds of success and at a much lower cost"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"than the previous owners could so those folks sell to HROW for almost nothing up front and hope for royalties. An added bonus for HROW shareholders is that the legacy business is scaled sufficiently now to actually generate cash so the cash burn from the new launches is offset"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"by cash generated by the legacy business. This is what makes HROW different than some random small cap pharma with a drug that may or may not ramp. They operate at zero FCF during their initial drug launches. Then if these do ramp (this is the part we don't know IF they ramp)"
X Link 2025-07-10T20:21Z [---] followers, [---] engagements

"New public $HROW article. It's free. https://seekingalpha.com/article/4800763-harrow-internal-100-target-ambitious-new-bloomberg-data-backs-it https://seekingalpha.com/article/4800763-harrow-internal-100-target-ambitious-new-bloomberg-data-backs-it"
X Link 2025-07-11T23:10Z [----] followers, [----] engagements

"@TOWiU2 it means they sold a lot more drug. Bloomberg is reporting June Vevye WAC of $41M compared to $23M in March for example. WAC excludes rebates and discounts so the actual revenue to $HROW is less. But everything else equal 4123"
X Link 2025-07-12T13:05Z [---] followers, [---] engagements

"$HROW imagine being so dumb you could look at this graph of EBITDA margins and conclude there's zero operating leverage in the business. You literally can't"
X Link 2025-07-12T14:44Z [---] followers, [----] engagements

"Dip in [----] margins was due to heavy spending sorting out manufacturing issues for 3e (very tricky) and launch costs for two new drugs Vevye and 3e compared to one Iheezo in 2023"
X Link 2025-07-12T14:44Z [---] followers, [---] engagements

"BTIG headline today: "Samsung Bioepis Deal Is a Good Example of the Reason to Own Harrow. With the Pieces in Place They Can Make Money Where Others Can't" Even sell side starting to understand $HROW's business model. ALMOST as if they read MVI articles 🤣"
X Link 2025-07-17T18:32Z [---] followers, [----] engagements

"@app_hyd https://investors.harrow.com/news-releases/news-release-details/harrow-names-greg-dipasquale-senior-vice-president-head https://investors.harrow.com/news-releases/news-release-details/harrow-names-greg-dipasquale-senior-vice-president-head"
X Link 2025-07-17T19:55Z [---] followers, [---] engagements

"$HROW new article inside my pay service"
X Link 2025-07-17T20:44Z [----] followers, [----] engagements

"You guys get the difference between founder CEOs and um the other guys right Think of examples of caretaker CEOs who've really killed it. Now tell me about the founder CEOs who have. See what I mean Get them early and 100x. Mark Baum $HROW will be 100x for me"
X Link 2025-07-18T15:10Z [----] followers, [----] engagements

"@TOWiU2 @app_hyd dude Greg works at $HROW. Make it a question instead of a statement the next time you're confused https://www.linkedin.com/in/greg-dipasquale-016526a/ https://www.linkedin.com/in/greg-dipasquale-016526a/"
X Link 2025-07-22T00:13Z [----] followers, [---] engagements

"one can quibble with those numbers but the TAM easily supports quite a bit more they are growing super fast and are very much on track. They're as likely to hit over as under imho but quibble as you see fit it won't matter"
X Link 2025-07-28T17:59Z [----] followers, [----] engagements

"Next let's consider the [--] new drugs acquired for almost nothing up front. $HROW's M&A terms: 10% royalties and zilch up front. Small drug companies take the deal bc HROW can sell those drugs way better than the original owners can. Those [--] drugs likely another $300M include"
X Link 2025-07-28T17:59Z [---] followers, [----] engagements

"Byqlovi and biosimilars for Lucentis and Eylea. Byqlovi competes with a [----] drug that had $165M in [----] despite having a generic and Byqlovi is a brand new better drug. The Lucentis biosimilar did $36M in [----] despite being early days the Eylea one launches soon"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"We are at $1.95B. $HROW will almost certainly acquire Melt a $1B+ potential drug over time though it will be well into the 2030's to get there. By [----] maybe $200m or $300M And they will acquire more and more drugs"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"Why would anyone doubt they will acquire more And not by issuing debt or equity or depleting the balance sheet. No they will offer nothing up front and the sellers will take a royalty. Let's look at the track record so far:"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"2023 Iheezo $300M drug $8M + 5% royalty [----] Vevye $1B drug $8M + 12% royalty [----] Byqlovi&biosimilars $300M drugs $1.6M + royalty tbd 2025/26 Melt ophthalmic $300M drug terms tbd"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"ok Melt hasn't happened yet but so far in [--] years that's [--] drugs that likely hit $1.6B for less than $20M up front. [----] isn't even over yet. Let's think that through shall we"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"We are already at $2.25B in [----] including Melt. But there will be more. Another $300M/yr $500M/yr Decent chance by [----] they add another $2B on top of what they have So. How exactly are they not getting to $2B"
X Link 2025-07-28T17:59Z [---] followers, [---] engagements

"$HROW website now updated to look like it's not [--] years old: https://investors.harrow.com/ https://investors.harrow.com/"
X Link 2025-07-30T20:22Z [----] followers, [----] engagements

"$IONQ Chris Monroe explicitly says quantum computing is at peak hype & predicts a "trough of disillusionment". Good short"
X Link 2025-08-02T19:23Z [----] followers, [----] engagements

"$ALC great at selling. New MoA for Tyrvaya = convince some doctors it's better for some patients. Expect nonsense posts by doctors like we saw with Miebo explaining the "science" they learned from reps. But Tyrvaya burns on installation. People hate when their eyes burn"
X Link 2025-08-05T12:56Z [----] followers, [---] engagements

"Consider Increlex bought from Ipsen for peanuts. Ipsen is too big for this drug. [---] patients a few years ago down to [--] Q4 [----]. [--] months as part of ETON and patient count [---] and heading up. But it gets waaaay better"
X Link 2025-08-08T14:40Z [----] followers, [---] engagements

"There are only [---] qualified patients in the US. Need to be [--] sd low IGF-1. Europe standard [--] sd. ETON study to match this standard. Zero doubt - none - that patients benefit. Vulnerable children. If approved [----] patients $300M revenue 4x [----] ETON total revenue"
X Link 2025-08-08T14:40Z [----] followers, [---] engagements

"That would never have happened on Ipsen's watch. ETON specializes in it. Increlex only one example. This will happen again and again and again with drugs in the pipeline already and with more M&A. Stock at $15 heading well north of $100. People don't get it yet but they will"
X Link 2025-08-08T14:40Z [----] followers, [---] engagements

"@niubi1988 are you mad bc I am making fun of $TSLA or bc you think that post was serious"
X Link 2025-08-10T12:41Z [----] followers, [--] engagements

"$HROW missed expectations of $66M revenue in the quarter with $64M. The miss is due to $5M in Other Specialty instead of the expected $10M. Other Specialty is filled with volatile no growth legacy products which are irrelevant"
X Link 2025-08-12T13:47Z [----] followers, [----] engagements

"$HROW down today bc Vevye revenue declined and Other Specialty (OS) came in $5M light. OS is volatile legacy drugs and nearly meaningless long term. Might be $5M higher next Q who cares. Vevye revenue recognition items shift revenue Q to Q. Vevye corrected for GAAP artifacts:"
X Link 2025-08-12T17:41Z [----] followers, [----] engagements

"$HROW article on my pay service:"
X Link 2025-08-12T18:20Z [----] followers, [----] engagements

""beat" vs "miss" = lame. Imagine being dumb enough to care about a "beat" for economic reasons. Short term I care bc dummies trade on it. It's highly reflexive. Smart people can care about how dumb people will react. That's the ONLY reason to care about a "beat". Re/ $HROW would"
X Link 2025-08-15T18:38Z [----] followers, [---] engagements

"anyone prefer $HROW came in at $70M on a "beat" but only because Immy shockingly outperformed expectations and the Fab [--] recovered to [----] levels but Iheezo and Vevye were tepid"
X Link 2025-08-15T18:38Z [----] followers, [---] engagements

"7) Possible shift in market's view on management. IR vastly improved and doubters increasingly look stupid - not just wrong but stupid - and business & stock performance combined with management's "never sell a share" attitude begets fandom"
X Link 2025-08-15T18:54Z [----] followers, [----] engagements

"$HROW $100 is coming. Should be sharply higher by Q3 [----] earnings and then $100 maybe before year end or maybe after Q4 [----] earnings. But $100 coming. And lots more after that"
X Link 2025-08-15T18:54Z [----] followers, [----] engagements

"@zipjet you're welcome But it won't be 150% yoy. It's $100M Q4 [----] and then $250M Q4 2027"
X Link 2025-08-16T13:59Z [----] followers, [--] engagements

"Plainly obvious that $HROW ttm leverage when they announce Q4 [----] earnings will be 2x forward leverage will be 1x and by YE [----] HROW will be unlevered unless there's some big buyback or special dividend or something. Everyone can see this right"
X Link 2025-08-18T20:24Z [----] followers, [----] engagements

"$NXST article out today"
X Link 2025-08-29T17:24Z [----] followers, [---] engagements

"$HROW Apparently Xiidra feels like lemon juice compared to Vevye or Miebo. The new DED drugs hurt less and work better. Especially Vevye"
X Link 2025-09-04T21:06Z [----] followers, [----] engagements

"I heard Xavier Worthy was injured and thought the obvious question any one would I wonder if his dad is the great @JamesWorthy42 & this is what Google's AI delivered:"
X Link 2025-09-06T17:51Z [----] followers, [----] engagements

"@finnishboycp @TOWiU2 More M&A is coming. It really is. The biosimilars they just bought are $80M/yr - per point - of market share. $HROW lowest cost distribution structure. Think about that advantage for a moment. Before biosimilars were Vevye and Iheezo. Melt is coming and more after that"
X Link 2025-09-06T19:42Z [----] followers, [---] engagements

"More M&A is coming. It really is. The biosimilars they just bought are $80M/yr - per point - of market share. $HROW lowest cost distribution structure. Think about that advantage for a moment. Before biosimilars were Vevye and Iheezo. Melt is coming $1B+ and more after that"
X Link 2025-09-06T19:51Z [----] followers, [----] engagements

"Another great interview today on CNBC with Dr. Marty Makary $HROW board member until he left Jan [--] [----] to run the FDA for the Trump administration. Anyone who thinks HROW will be surprised by new pharma policies might want to reflect on this"
X Link 2025-09-10T16:58Z [----] followers, [----] engagements

"Also anyone who thinks $HROW is somehow not a serious company might want to ask themselves why the sitting FDA commissioner was on its board"
X Link 2025-09-10T17:16Z [----] followers, [---] engagements

"BBG Iheezo data = low quality; Q2 BBG 35k units vs 49k actual. FWIW they have Iheezo flat in August but caveat emptor on that"
X Link 2025-09-12T15:37Z [----] followers, [---] engagements

"$HROW investor day agenda: pivot to #crypto / #AI ophthalmology CYCLO-COIN and VEVY-AI: https://www.harrow.com/news-releases/news-release-details/harrow-announces-agenda-and-speakers-investor-analyst-day https://www.harrow.com/news-releases/news-release-details/harrow-announces-agenda-and-speakers-investor-analyst-day"
X Link 2025-09-15T13:25Z [----] followers, [----] engagements

"Long grumpy post about shorting motivated by quantum computing stocks eg $IONQ which are all basically frauds. Apologies in advance @MartinShkreli. I suspect being right on the facts is not good enough for a short. It's plenty good enough for a long position. There's no way"
X Link 2025-09-18T17:30Z [----] followers, [----] engagements

"market sentiment can cause longs any issues if they can wait it out. A really cheap stock one is long on when it gets cheaper just buy more maybe the company repurchases shares you wind up with an even better outcome over time bc of a temporary bit of market insanity. And it"
X Link 2025-09-18T17:30Z [----] followers, [---] engagements

"doesn't take long to win eg $NXST. Market has put a 5x FCF multiple on it over the past [--] years I've been involved and I'm up 35x. No need for the market to ever "get it" just grow and generate FCF and buyback stock and pay dividends and the market can be as dumb today as it"
X Link 2025-09-18T17:30Z [----] followers, [---] engagements

"tied to any major currency and instead of a commodity it trades on fantasy. Same with bitcoin albeit over a shorter time frame. Silver used to be money & now trades like a commodity. Maybe that eventually happens to gold but [--] years later there's no sign of rationality yet"
X Link 2025-09-18T17:30Z [----] followers, [---] engagements

"For a short one needs to either front run the "voting machine" - typical Haruspex track record suuucks at this - or a catalyst. With quantum computing there's no catalyst imho. It'd be different if there were a deadline like a drug trial or a bankruptcy filing. Rant over"
X Link 2025-09-18T17:30Z [----] followers, [---] engagements

"And people STILL don't get broadcasters. I've been involved at $NXST since [----] and have a 35x on it despite the fact that NXST trades today at 5x FCF just like it did in [----]. Other broadcasters only did ok. Management matters"
X Link 2025-09-19T14:53Z [----] followers, [---] engagements

"Did anyone see the $IONQ CEO on last night's "Pump with Cramer" show I meant to record it and forgot @MartinShkreli"
X Link 2025-09-23T15:22Z [----] followers, [---] engagements

"Cramer with the hard hitting skeptical line of questioning we have come to expect from him in cases of obvious scams like $IONQ amiright @MartinShkreli https://www.youtube.com/watchv=4ejZGiJ4zs4 https://www.youtube.com/watchv=4ejZGiJ4zs4"
X Link 2025-09-23T17:17Z [----] followers, [---] engagements

"@ChrisOlin $HROW is going to $500+ by the end of the decade and then up more from there. People are catching on but slowly"
X Link 2025-09-24T16:40Z [----] followers, [---] engagements

"$HROW shorts have only lost $100M or so since the $22 low in March this year. About 5M shares short now so when the share price hits $100 over the next [--] months that works out to another $500M of losses. Ouch"
X Link 2025-09-24T22:10Z [----] followers, [----] engagements

"@Oddhootcapital My convos w/ $HROW pod shorts: rational types look for "disappointment" on guidance or street; some also have crackpot POV on the company; most think Mark is "promotional" - tbf he is relentlessly optimistic - but can't tell he's also brilliant. Some real dummies in this group"
X Link 2025-09-25T13:56Z [----] followers, [---] engagements

"$HROW now owns Melt. Expect $400 ASP initially $200 ASP for broad use label. I'll leave you to do the arithmetic"
X Link 2025-09-26T16:12Z [----] followers, [----] engagements

"$HROW I should have added that Melt has zero competition. Only alternatives are opioids or needles. Quick question: if someone you care about needs mild/medium pain management would you prefer fentanyl a needle with the same drug as Melt or a [--] second sublingual tablet"
X Link 2025-09-26T16:17Z [----] followers, [---] engagements

"$HROW Before Iheezo patients getting monthly bilateral eye injections reported needing 1-2 days before resuming normal activity. Iheezo takes a few hours. Patients recover "3 to [--] weeks of their life in a given year" - Dr. Raj Patel"
X Link 2025-09-26T18:55Z [----] followers, [---] engagements

"Good lord what a stupid post. $ORCL market cap is $800B debt is $100B"
X Link 2025-09-28T15:07Z [----] followers, [---] engagements

"Of course they are still sell side so they go on to say some silly things later in the note. But the note does get off to a good start"
X Link 2025-09-29T14:22Z [----] followers, [---] engagements

"@genejchan OMG LOLOLOL the thesis is $IONQ is the "valuable" one 🤣🤣🤣🤣🤣🤣"
X Link 2025-10-09T19:02Z [----] followers, [---] engagements

"@TylerRe98565311 $IONQ are literally con men who are lying to you. Glad you had a nice outcome. No position btw never had one. Just. be careful of snake oil"
X Link 2025-10-14T11:05Z [----] followers, [---] engagements

"@DrEliDavid Blerg. They sell stock at absurd prices and raise tons of cash. How does $IONQ drop 99% when they have 7.5% of their market cap in cash The business is a fraud but it won't drop 99%. See $GME. Sold shares into bubble now has $9.2B cash&bitcoin market cap $10.3B"
X Link 2025-10-14T13:59Z [----] followers, [---] engagements

"Quantum frauds will NOT drop 99% from here bc they sell stock into the bubble. How does $IONQ drop 99% with 7.5% market cap in cash Consider $GME. Sold shares into bubble now $9.2B cash & bitcoin market cap $10.3B. See what I mean"
X Link 2025-10-14T14:01Z [----] followers, [---] engagements

"@iewney Thoughts & prayers. Fortunately it can't go to zero despite being a worthless company bc the stock they dumped into the bubble is now cash on the b/s. Like $GME which now trades at cash. Mgmt dumped $1B into the bubble at the expense of ya know whoever was buying the bubble"
X Link 2025-10-16T19:32Z [----] followers, [---] engagements

"@genejchan $IONQ computers literally cannot add two [--] digit numbers together today. The thing you think happened did not happen. And it has been debunked. You're welcome"
X Link 2025-10-16T20:35Z [----] followers, [---] engagements

"Meanwhile Xiidra sucks and BLCO is lowering guidance there. BC Xiidra is not an SA drug. And we all knew this already right There's clinical trial data. Xiidra data sucks. Restasis data sucks same with Cequa and all the other DED drug data for everything except the SAs"
X Link 2024-07-31T15:31Z [----] followers, [---] engagements

"And the clinical trial data that doesn't suck Well there are two and they are both SA drugs both developed by Novaliq and licensed in the US. Miebo to $BCLO and Vevye to $HROW. The data are not hard to read. I am a scientist but you don't have to be one to read these"
X Link 2024-07-31T15:31Z [----] followers, [---] engagements

"$BCLO and $HROW clinical trial data. Adverse events profile: Xiidra 51.7% Miebo 11.4% Vevye 10.2%. Efficacy data also superior for the SA drugs Miebo & Vevye. How obvious is it that drugs that work faster and better and don't hurt to use will win market share"
X Link 2024-07-31T15:53Z [----] followers, [---] engagements

"$HROW 10yr revenue CAGR 35%. Up each yr except pandemic then down a smidge. It's like watching $BRKB $BRKA Warren Buffett "compound"😆during his old partnership days"
X Link 2024-12-02T12:39Z [----] followers, [----] engagements

"$ETON article. It's free. You're welcome ;-) https://seekingalpha.com/article/4788714-eton-pharmaceuticals-set-to-dominate-orphan-drug-niche https://seekingalpha.com/article/4788714-eton-pharmaceuticals-set-to-dominate-orphan-drug-niche"
X Link 2025-05-21T12:18Z [----] followers, [---] engagements

"I first bought $ETON last year at $3.50 now $19. And the amazing thing is that I own more now than I did then at a much lower price. Execution is amazing management just killing it. $100 is coming maybe more"
X Link 2025-05-21T13:21Z [----] followers, [----] engagements

"$ETON is about to dominate the Orphan Drug niche the way $HROW dominates the compound pharmacy niche"
X Link 2025-05-22T23:29Z [----] followers, [----] engagements

"@TOWiU2 @WallStPirate $BLCO began a huge DTC marketing campaign with the start of [----] possibly you have seen their TV commercials That's what you are seeing on the graph. Obviously it isn't cheap so likely Miebo is losing money for now"
X Link 2025-06-02T13:27Z [----] followers, [---] engagements

"Shameless plug: new article out on $HROW and $ETON on my pay service"
X Link 2025-06-24T17:48Z [----] followers, [----] engagements

"@TR_LA2 $HROW can't compete on DTC ad spending with $BLCO just like they can't afford [---] sales reps (yet). Miebo is killing it but BLCO is likely burning a ton of cash on it so far. HROW has to launch efficiently and hope that having the best drug and the best access will be enough"
X Link 2025-07-10T20:45Z [----] followers, [---] engagements

"Xiidra [----] $487M [----] $390M [----] $364M Q2 [----] down 8% YOY. Interest on $1.75B up front $150M/yr no idea if they triggered milestones. What's the EBITDA margin on Xiidra 50% maybe Rapidly approaching where EBITDA can't pay the interest even on the up front"
X Link 2025-08-03T16:33Z [----] followers, [---] engagements

"$HROW $ALC DED drug Tyrvaya: poor trial data but why read clinical trials when salespeople are honest & attractive & really want to hear your opinion doctor and have you been working out Here have a muffin. Poor results matter eventually e.g. Xiidra. Vevye has amazing data"
X Link 2025-08-05T12:56Z [----] followers, [----] engagements

"@AktienAkademie You mean how do you do the arithmetic $HROW Q2 net debt $169M Q2 EBITDA $17M & growing fast & Q4 seasonally strong (Q1 seasonally weak). Sub 2x trailing results from e.g. $65M 2H EBITDA and at least $10M FCF or $60M 2H EBITDA and $20M FCF etc. Does that help"
X Link 2025-08-16T14:09Z [----] followers, [---] engagements

"@themateuszcaban @ChrisOlin @MitchMartan98 wisdom"
X Link 2025-09-25T11:22Z [----] followers, [---] engagements

"Some may see this & think: hmm added biosimilars and didn't raise guidance. is something wrong Understandable but no. Investors asked $HROW to underpromise/overdeliver & starting with [----] guidance - which they beat despite some issues - they have been. That's what this is"
X Link 2025-10-02T17:13Z [----] followers, [----] engagements

"@RevShark Started [--] yrs ago. Investors (including me) convinced them in late '23 '24 guide was lowball. Also took advice re/ "at least" guidance. '24 "at least" $180M '25 "at least" $280M. $HROW "gets it" now. This will become obvious to everyone might take a few more quarters though"
X Link 2025-10-05T00:11Z [----] followers, [---] engagements

"@commonsenseplay Dude it's not going to go bankrupt. $RGTI has a $13B market cap & issues stock as needed; just did $350M in Q2. Now have $575M cash no debt. [----] burn=$60M. Don't make bears look stupid ok That's not helpful"
X Link 2025-10-05T17:03Z [----] followers, [---] engagements

"Quantum computing=hype & some frauds (cough cough $IONQ $QBTS) but NOT about to go bankrupt. Example: $RGTI $13B market cap issue stock as needed; raised $350M in Q2 '25. Now $575M cash no debt. [----] burn=$60M. Not going bankrupt ok RGTI also not a fraud imho. Seem honest"
X Link 2025-10-05T17:20Z [----] followers, [----] engagements

"$HROW PR today = IR problems = fixed. Immy CEO Saharek out days after presenting at investor day. PR doesn't mention him but new Head of Quality Bridseida Cruz is "known for driving FDA remediation". Market jumps to conclusion: FDA problems https://www.harrow.com/news-releases/news-release-details/imprimisrx-announces-leadership-changes https://www.harrow.com/news-releases/news-release-details/imprimisrx-announces-leadership-changes"
X Link 2025-10-06T22:58Z [----] followers, [----] engagements

"Reality: Immy grew like crazy when Mark was running it and now that Mark needs to pay attention to branded pharma he needs someone to handle Immy. Saharek has maybe always been in over his head. New Immy CEO Frank Mullery ran a $1B division at Mylan; he can handle growing Immy"
X Link 2025-10-06T22:58Z [----] followers, [---] engagements

"Bridseida Cruz has been with $HROW since July. Not a new hire. Resume is great. And she was not hired bc of FDA issues. How do we know this https://www.linkedin.com/in/bridseida-cruz-844492160/ https://www.linkedin.com/in/bridseida-cruz-844492160/"
X Link 2025-10-06T22:58Z [----] followers, [----] engagements

"Because the FDA's website shows nothing; and because an 8k from 9/12/25 says no FDA problems https://www.sec.gov/Archives/edgar/data/1360214/000149315225013268/form8-k.htm https://www.sec.gov/Archives/edgar/data/1360214/000149315225013268/form8-k.htm"
X Link 2025-10-06T22:58Z [----] followers, [----] engagements

"My take: $HROW didn't expect a reaction to the PR. Just another day at the office. But after generating good will with that great investor day buy side added $HROW has their boss is asking: did we buy a stock with FDA trouble They didn't but the confusion is understandable"
X Link 2025-10-06T22:58Z [----] followers, [----] engagements

"@mvcinvesting Yeah some crazy conspiracy theories out there. $HROW IR has been on the phone all day today quashing this one"
X Link 2025-10-09T17:10Z [----] followers, [---] engagements

"@John_Porter10 ugh why do people keep saying dumb stuff like this They will NOT run out of money because they issued shares into the bubble and will again. $575M cash burn rate is $60M/yr. Not running out"
X Link 2025-10-15T11:36Z [----] followers, [---] engagements

"$IONQ mgmt dumped $1B of stock into the bubble. $RGTI CEO owns no shares. Sold them all. Can't zero though. Companies sold shares into the bubble=cash on the b/s now. $GME did that too & trades at cash now. These will all trade at cash some day. Management knows that"
X Link 2025-10-16T19:39Z [----] followers, [----] engagements

"$IONQ $QBTS $RGTI shorting quantum frauds is fraught with peril but one can also make some nice coin. Tempted to say "so long and thanks for all the fish" at this point"
X Link 2025-10-21T14:17Z [----] followers, [---] engagements

"If the previous comment makes sense to you great. If it doesn't and if you think you know what's up with quantum computing that's a major red flag. That doesn't mean quantum computers won't be useful someday. But until one wraps their head around how useful and when"
X Link 2025-10-21T14:17Z [----] followers, [--] engagements

"prolly $GME all over again. Or $BYND or weed stocks etc. And can you tell which one's are frauds $RGTI overpriced but = fraud. CEO owns zero shares is careful about what he says no risk of prison imho. Some other CEO's seem more open to the idea 🤣jk"
X Link 2025-10-21T14:17Z [----] followers, [---] engagements

"Prediction: qc companies & management dump shares bigly into bubble. Honest CEO's e.g. $RGTI = pump discuss goals and achievements. Compare to $IONQ CEO public comments. Eventually all trade at cash plus a bit. Value cash raised selling into the bubble. Just like $GME today"
X Link 2025-10-21T14:17Z [----] followers, [---] engagements

"There's a meme etf $MEME Top [--] holdings include quantum frauds $IONQ $QUBT $QBTS $RGTI. Incredible real time study of bubble psychology. Some true believers some traders trying to front run the FOMO some con men & some trying to time the inevitable crash as shorts"
X Link 2025-10-21T22:39Z [----] followers, [----] engagements

"@themateuszcaban @SPAC_Infleqtion I don't think I understand the question I think I've made my POV pretty clear on quantum computing stocks. What's the confusion"
X Link 2025-10-22T10:48Z [----] followers, [--] engagements

"@MartinShkreli Don't they have $10/share of cash I can see $IONQ going to $10 but how can it go to zero"
X Link 2025-10-22T10:56Z [----] followers, [---] engagements

"@themateuszcaban @SPAC_Infleqtion $CCCX prolly trades at cash from selling shares into bubble once bubble ends. But it's a real company & 1/4 market cap of frauds=long CCCX/short $IONQ $QBTS $RGTI $QUBT might make sense. Citron's idea. Not crazy. Maybe better to just short the other [--] though"
X Link 2025-10-22T17:30Z [----] followers, [---] engagements

"Just a quick reminder that all the quantum frauds will trade at a bit more than the cash on their balance sheets at some point. They smartly dumped tons of shares into the bubble so no risk of a zero. $IONQ has $10/share of cash for example. Can't hit zero for this reason"
X Link 2025-10-22T19:07Z [----] followers, [---] engagements

"$HROW Tegus interview with a DED specialist: "Restasis doesn't work at all but insurance companies want us to try it first. Sometimes we have to try it but it really doesn't work. Xiidra works differently than all the cyclosporines"
X Link 2025-11-16T21:06Z [----] followers, [----] engagements

"Quantum frauds are doing what they should do: settle at about cash per share over time. It's meme vs reality. Look at $GME to see the future of $IONQ $RGTI $QUBT $QBTS I'm a physicist. What the longs in this space think is true about the science = what is really true"
X Link 2025-11-21T17:01Z [----] followers, [---] engagements

"@genejchan Do you actually believe in this stuff or is it just a con Naive but innocent or clever but nefarious In case it's the former the proper read is from the $RGTI CEO. Science project owns zero shares. You're welcome. If it's the latter then you already know ;-)"
X Link 2025-11-21T17:13Z [----] followers, [---] engagements

"New $HROW article out today on my pay service: https://seekingalpha.com/mp/1414-concentrated-value-with-mvi/articles/6227577-hrow-end-of-the-weirdos https://seekingalpha.com/mp/1414-concentrated-value-with-mvi/articles/6227577-hrow-end-of-the-weirdos"
X Link 2025-11-22T03:43Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

creator/x::Michigan_Value
/creator/x::Michigan_Value